2024 Annual Meeting | P6 - Poster Session 06

Date Tuesday 04/16/24

Time 08:00 AM - 09:00 AM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) General Neurology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, ��ɫ��, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), Global Health and Neuroepidemiology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neurocritical Care, Neuromuscular and Clinical Neurophysiology (EMG), Pain

Learning Objectives View the latest research on a variety of topics. Posters are available in-person or online.

CME Available 0.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Interactive

Event Timeline
08:00 AM - 09:00 AM MDT	Abstract	9-001 - Biofluid Activity and Levels of the Angiotensin-converting Enzyme Are Surrogates for Diverse Cerebrospinal Fluid Amyloid-beta Effects in Dementia with Lewy Bodies and Alzheimer’s Dementia Fabricio F. De Oliveira, MD, PhD, BBA, MSc, FAAN
08:00 AM - 09:00 AM MDT	Abstract	9-002 - Nuclear Transport Receptors as Novel Modifiers of C9orf72 Pathology Feilin Liu, MD
08:00 AM - 09:00 AM MDT	Abstract	9-003 - Diagnostic Applications of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia Gregory S. Day, MD, MSc, FAAN
08:00 AM - 09:00 AM MDT	Abstract	9-004 - Medial Prefrontal Acetylcholine Release Is Modulated by Stimulus During Interval Timing Qiang J. Zhang, MD
08:00 AM - 09:00 AM MDT	Abstract	9-005 - The Relationship Between GSK3?eta Activity and TDP-43 Mediated Neuritis in Neurodegenerative Diseases Eu Jene Choi, MD, PhD(c)
08:00 AM - 09:00 AM MDT	Abstract	9-007 - The Neural Mechanism of Human Attention Shift Mohammad Dastjerdi, MD
08:00 AM - 09:00 AM MDT	Abstract	9-009 - Association of Metabolic Syndrome with the Development of Alzheimer’s Disease: A Systematic Review with Meta-analysis Claudia Cruzalegui Bazán
08:00 AM - 09:00 AM MDT	Abstract	9-010 - Computational Models of Age-associated Cognitive Slowing and Memory Loss Sanya Ahmed
08:00 AM - 09:00 AM MDT	Abstract	9-012 - Unraveling the Earliest Phases of Vascular Cognitive Impairment and Dementia by Establishing a Large USA CADASIL Consortium Michael D. Geschwind, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	9-013 - A Challenging New Diagnosis of Neurofibromatosis Type-1 with Uncommon Vascular Manifestations in an Elderly Female Isaac Smith, DO, MS
08:00 AM - 09:00 AM MDT	Abstract	9-014 - Pathogenic Amyloid-beta Precursor Protein (APP) Duplication: A Rare Case of Early Onset Alzheimer's Dementia (EOAD) with Probable Cerebral Amyloid Angiopathy (CAA) Alexander Maslov, MD
08:00 AM - 09:00 AM MDT	Abstract	9-015 - A Clinical Puzzle: CSF1R Leukoencephalopathy Presenting with Aphasia and Behavior Change in the Guise of TBI Sequelae Kyle R. Marden, MD
08:00 AM - 09:00 AM MDT	Abstract	9-016 - Retrospective Study of Multi-site CADASIL: Implications for Clinical and Research Practice Michael D. Geschwind, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	9-017 - Novel Stop-gain SORL1 Mutation in a Peruvian Family with Alzheimer's Disease of the PeADI Study Mario R. Cornejo Olivas, MD
08:00 AM - 09:00 AM MDT	Abstract	15-001 - Encephalitis of Unknown Etiology in Colombia: A Multicenter Case Series David Acero-Garces, MD
08:00 AM - 09:00 AM MDT	Abstract	15-002 - Estimating Income Loss from Neurological Disorders Globally, 1990–2019 Jeremy D. Dalos
08:00 AM - 09:00 AM MDT	Abstract	15-004 - Military Service and Survival with Amyotrophic Lateral Sclerosis Ian Tang, PhD
08:00 AM - 09:00 AM MDT	Abstract	3-001 - The Impact of Social Determinants of Health in the Morbidity of Patients with Huntington Disease Jorge E. Patino Murillas, MD
08:00 AM - 09:00 AM MDT	Abstract	3-002 - A Unique Case of Late Adult Onset Dyskinesia due to Adenylyl Cyclase 5 Mutation Gunjanpreet Kaur, MD
08:00 AM - 09:00 AM MDT	Abstract	3-003 - The Impact of Antidopaminergic Medication on Longitudinal Clinical Progression in Huntington Disease Randal Hand
08:00 AM - 09:00 AM MDT	Abstract	3-004 - Dissemination of VMAT-2 Inhibitors: A New Class of Drug for Tardive Dyskinesia and Huntington’s Disease Michiko K. Bruno, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	3-005 - Case Report: Two Patients of Mexican Heritage with Huntington’s Disease-like 2 Sarah Horn, MD
08:00 AM - 09:00 AM MDT	Abstract	3-006 - Olfactory Dysfunction as an Indicator of Cognitive and Motor Impairment Severity in Huntington’s Disease Shayan A. Zadegan, MD
08:00 AM - 09:00 AM MDT	Abstract	3-008 - A Pilot Study to Evaluate the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease Erin Furr-Stimming, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	3-009 - Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington’s Disease Shuhei Shiino
08:00 AM - 09:00 AM MDT	Abstract	3-010 - Preparatory Check to Assess Equipment and Participant Comfort Prior to a Televisit in Huntington’s Disease Samuel A. Frank, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	3-011 - Late-onset Chorea Associated with Essential Thrombocythemia Molly Perkins, MD
08:00 AM - 09:00 AM MDT	Abstract	3-012 - How Robust Are Biomarkers for the Huntington Disease Continuum? Maria Rudrud
08:00 AM - 09:00 AM MDT	Abstract	3-013 - GAA-FGF14 Disease: Defining Its Frequency, Molecular Basis, and 4-aminopyridine Response in a Large Cohort of Patients with Downbeat Nystagmus David Pellerin, MD
08:00 AM - 09:00 AM MDT	Abstract	3-014 - Automated Video-based Characterization of Movement Quality in a Phase III Clinical Trial of Troriluzole in Subjects with Spinocerebellar Ataxia Melissa Beiner
08:00 AM - 09:00 AM MDT	Abstract	3-015 - Prevalence Estimation of the Main Spinocerebellar Ataxias in South America: A Meta-analysis Approach Milagros Galecio-Castillo, MD
08:00 AM - 09:00 AM MDT	Abstract	3-016 - Supra and Infratentorial Atrophy in Cerebellar Ataxias: Unveiling Distinctions Across Different Etiologies Edoardo G. Spinelli, MD
08:00 AM - 09:00 AM MDT	Abstract	3-017 - Spinocerebellar Ataxia 27B with Grip Myotonia: Case Report and Literature Review Yasuko Mori, Sr., MD
08:00 AM - 09:00 AM MDT	Abstract	3-018 - Foundation Sponsored Genetic Counseling and Testing Program for Spinocerebellar Ataxia (SCA) Types 1, 2, and 3: Analysis of the First Two Years of Service Kelsey Trace, OTD
08:00 AM - 09:00 AM MDT	Abstract	3-019 - Clinical and Autonomic Features Suggest Phenoconversion from Sporadic Adult-onset Ataxia to Clinically Probable Multiple System Atrophy Tina Liu, MD
08:00 AM - 09:00 AM MDT	Abstract	3-020 - Deep Brain Stimulation in Spinocerebellar Ataxias: Review Surabhi A. Garg, MD
08:00 AM - 09:00 AM MDT	Abstract	12-001 - Long-term Safety and Tolerability of Zavegepant 10 mg Nasal Spray in the Acute Treatment of Migraine Among Female Adults Samantha Sweeney, Other
08:00 AM - 09:00 AM MDT	Abstract	12-002 - The Effect of Sodium Valproate as a Migraine Abortive: A Systematic Review and Network Meta-analysis Victoria Damore
08:00 AM - 09:00 AM MDT	Abstract	12-003 - Characterization of the Prevalence and Treatment Strategies of Migraine in Patients with Refractory Spontaneous Intracranial Hypotension Ahmed Taha Shahzad
08:00 AM - 09:00 AM MDT	Abstract	12-004 - Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine in Women: Results from 2 Randomized, Placebo-controlled Clinical Trials Samantha Sweeney, Other
08:00 AM - 09:00 AM MDT	Abstract	12-005 - Mexiletine for the Treatment of Refractory Chronic Migraine: A Retrospective Chart Review Lucia Liao, MD
08:00 AM - 09:00 AM MDT	Abstract	12-006 - EMERGE Study: An Open-label Evaluation of the Efficacy and Safety of AXS-07 (MoSEIC™ meloxicam-rizatriptan) for Migraine in Adults with Prior Inadequate Response to an Oral CGRP Inhibitor Peter J. McAllister, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	12-007 - Pressure on Myofascial Trigger Points Reproduces Migraine and Tension Type Headache Phenotypes in Persistent Post-traumatic Headache: Implications of Physical Findings on the Physiology and Diagnosis of Headache Disorders Michael R. Sorrell, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	12-008 - Prospective Observational Pilot Study of Low-dose Naltrexone in Patients with Chronic Migraine with Comorbid Fibromyalgia Arashleen K. Pannu
08:00 AM - 09:00 AM MDT	Abstract	12-009 - Efficacy of EP102 (Oral Fospropofol) for the Acute Treatment of Migraine in an Open-label Proof-of-concept Trial: Effect of Time to Treatment Allen H H. Heller, MD, MPH
08:00 AM - 09:00 AM MDT	Abstract	12-010 - Hemicrania continua successfully treated long-term with botulinum toxin type A: a case report Fatima Traore, MD
08:00 AM - 09:00 AM MDT	Abstract	6-001 - Understanding the Link Between Psoriasis and Multiple Sclerosis: A Systematic Review and Meta-analysis Amr Salem, MBBCH
08:00 AM - 09:00 AM MDT	Abstract	6-002 - Prevalence and Spectrum of Cognitive Phenotypes in Multiple Sclerosis and Related Risk Factors Denise Diniz Carneiro
08:00 AM - 09:00 AM MDT	Abstract	6-003 - Synaptic Injury in the IPL of the Retina Is a Predictor of Progression in Multiple Sclerosis Christian Cordano, MD, PhD
08:00 AM - 09:00 AM MDT	Abstract	6-004 - A Sensor-based Data Capture Solution for Home-based Gait Assessment: The GAIT-HUB System Timothy Ko
08:00 AM - 09:00 AM MDT	Abstract	6-005 - Retinal Layer Thinning for Monitoring Disease-modifying Treatment in Relapsing Multiple Sclerosis—Evidence for Applying a Rebaselining Concept Gabriel Bsteh, MD
08:00 AM - 09:00 AM MDT	Abstract	6-006 - Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod Ludwig Kappos, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	6-007 - Usability and Validation of Smartphone-based Neuroperformance Tests in Multiple Sclerosis Katherine Beshears
08:00 AM - 09:00 AM MDT	Abstract	6-008 - Reliability and External Validity of Digital Passive Gait Tracking in MS Laurent Servais
08:00 AM - 09:00 AM MDT	Abstract	6-009 - A Novel Methodology for Developing Smartphone-instrumented Tests for Assessing Movement, Dexterity, and Balance in Neurological Patients: Technical Verification of Ground Truth Datasets, and Analytical and Clinical Validation of Digital Biomarkers Alejandro Ena Bernad
08:00 AM - 09:00 AM MDT	Abstract	6-010 - Correlations Between Traditional Disability and Oculometric Measures in Multiple Sclerosis Sarah Levy, PhD
08:00 AM - 09:00 AM MDT	Abstract	6-011 - Prognostic Value of Serum Neurofilament Light Chain for Disease Activity in Patients with Relapsing Multiple Sclerosis: Results from Subgroup Analysis Based on Body Mass Index and Age from the Phase 3 ASCLEPIOS I/II Trials Enrique Alvarez, MD, PhD
08:00 AM - 09:00 AM MDT	Abstract	6-012 - Exploring the Relationship Between Temperament Traits, Psychological Comorbidity, and Functional Disability Assessed with the WHOSAS 2.0 in Persons with Multiple Sclerosis Carmenrita Infortuna
08:00 AM - 09:00 AM MDT	Abstract	6-013 - Digital Facial Analysis Correlates with Mood and Cognitive Outcomes with People with MS Alyssa Nylander, MD, PhD
08:00 AM - 09:00 AM MDT	Abstract	6-014 - Relapse-associated Worsening and Progression-independent Relapse Activity in Ozanimod-treated Participants with Relapsing Multiple Sclerosis from the RADIANCE and DAYBREAK Trials Bruce A. Cree, MD, PhD, MAS, FAAN
08:00 AM - 09:00 AM MDT	Abstract	6-015 - Eight-point Reliable Change on Symbol Digit Modalities Test with Ozanimod: Findings from the Phase 3 SUNBEAM and DAYBREAK Extension Trials James Appio
08:00 AM - 09:00 AM MDT	Abstract	6-016 - Prognostic Factors of Disease Activity in Newly Diagnosed Teriflunomide-treated Patients with Multiple Sclerosis—A Nationwide Danish Study Mie R. Mahler, MD
08:00 AM - 09:00 AM MDT	Abstract	6-017 - Depression Symptoms Moderate Link Between Infratentorial and Cervical Cord T2 Lesions on Gait Speed in Relapsing-remitting Multiple Sclerosis Hanaan Bing-Canar, PhD
08:00 AM - 09:00 AM MDT	Abstract	7-001 - Neurology Residency Didactics: A Survey of Program Directors Harry Sutherland, MD
08:00 AM - 09:00 AM MDT	Abstract	7-002 - ��ɫ�� Priority Setting: A Multi-stakeholder Survey Study of the Didactic Curriculum of an Adult Neurology Residency Program Sanem P. Uysal, MD
08:00 AM - 09:00 AM MDT	Abstract	7-003 - Implementing and Assessing a Neuropalliative Communication Curriculum for Neurology Resident Physicians Eileen Harrigan, MD
08:00 AM - 09:00 AM MDT	Abstract	7-004 - Disseminating Neuropalliative Care ��ɫ�� via an Adaptable Curriculum: A Multi-site Feasibility Trial Eileen Harrigan, MD
08:00 AM - 09:00 AM MDT	Abstract	7-005 - Evaluating the Effectiveness of a Narrative Medicine Curriculum for Neurology Residents Lauren K. Offerle, MD
08:00 AM - 09:00 AM MDT	Abstract	7-006 - Curricular Needs Assessment and Application of Team-based Learning for Neurology Residency Curricular Gaps Patricia Jokl Graese, MD
08:00 AM - 09:00 AM MDT	Abstract	7-007 - X + Why: Rethinking the Neurology Residency Curriculum Toni Cao, MD
08:00 AM - 09:00 AM MDT	Abstract	7-008 - Variability in Brain Death ��ɫ�� Across US Neurology Residency Programs Getasha Doobay, MD
08:00 AM - 09:00 AM MDT	Abstract	1-001 - Seizures in the Leukodystrophies Ashley N. Hackett, MD
08:00 AM - 09:00 AM MDT	Abstract	1-002 - To Select or Not to Select: Evaluating the Effectiveness of the SeLECT Score in Predicting the Risk of Post-stroke Epilepsy: A Systematic Review Muhammad Ahmed Ayaz, MBBS
08:00 AM - 09:00 AM MDT	Abstract	1-003 - An Analysis of Acute Seizure Presentation in Post-stroke Patients in the Emergency Department in Detroit Melissa Ly, MD
08:00 AM - 09:00 AM MDT	Abstract	1-004 - Description of Gastrointestinal Symptoms in Patients with New-onset Refractory Status Epilepticus (NORSE) Anima Shrestha, MD
08:00 AM - 09:00 AM MDT	Abstract	1-005 - EEG and Seizure Characteristics of Adults with Neurocysticercosis-associated Epilepsy at the University Teaching Hospital in Lusaka, Zambia Melody T. Asukile, MBBS
08:00 AM - 09:00 AM MDT	Abstract	1-006 - Post-traumatic Epilepsy: Prevalence and Follow-up Among Trauma Patients Daniel Kotas
08:00 AM - 09:00 AM MDT	Abstract	1-007 - MindMapp: Revolutionizing Depression Diagnosis and Management Through EEG and AI Chatbot Integration Abel M. Thomas
08:00 AM - 09:00 AM MDT	Abstract	1-009 - Ictal Migraine Following Hemipsherectomy Sudheesh Ramachandran, MBBS
08:00 AM - 09:00 AM MDT	Abstract	1-010 - Analysis of Real-world Characteristics of Patients with CDKL5 Deficiency Disorder Enrolled for Ganaxolone Treatment John A. Flatt, MD
08:00 AM - 09:00 AM MDT	Abstract	1-011 - Serotonin Syndrome Complicated by Status Epilepticus: A Literature Review Muskan Rawoot, MD
08:00 AM - 09:00 AM MDT	Abstract	1-012 - Concordance of Epileptiform Discharges on Video-electroencephalogram (EEG) with the Brain Imaging of Focal Lesions in Drug Resistant Epilepsy: Experience from a Tertiary Centre in India Sidharth Suresh, MD, MBBS
08:00 AM - 09:00 AM MDT	Abstract	1-013 - Characteristics of Non-diagnostic Admissions to the Epilepsy Monitoring Unit Nimit N. Desai, MD
08:00 AM - 09:00 AM MDT	Abstract	1-014 - Utility of Tilt Table Testing in Management of Seizure-like Activity After Inconclusive Epilepsy Monitoring Unit Admission Krystyna C. Phillips, MD
08:00 AM - 09:00 AM MDT	Abstract	1-015 - Effect of Standardized Neurologic and Psychiatric Evaluation on Prognosis for Patients Diagnosed with Functional Seizures in the Epilepsy Monitoring Unit: A Quality Improvement Initiative Kelly A. Boylan, MD
08:00 AM - 09:00 AM MDT	Abstract	1-016 - Long-term EEG Utilization After Ambulatory EEG?(aEEG)?versus Epilepsy Monitoring Unit (EMU)?Admission in US Veterans Tae Kim, MD
08:00 AM - 09:00 AM MDT	Abstract	10-001 - First Case of Optic Nerve Cavernoma in the United States Hispanic Population Aygun Asgarli, MD
08:00 AM - 09:00 AM MDT	Abstract	10-002 - A Child with Autosomal Recessive Leber Hereditary Optic Neuropathy Nhayoung Hwang, MD
08:00 AM - 09:00 AM MDT	Abstract	10-003 - Visual Manifestations in the Setting of Perinuclear Antineutrophilic Cytoplasmic Antibody (P-ANCA) Vasculitis Naga Pradyumna Kothapalli, MD
08:00 AM - 09:00 AM MDT	Abstract	10-004 - Lymphomatoid Granulomatosis Presenting with a Third Nerve Palsy Philip T. Kuball, MD
08:00 AM - 09:00 AM MDT	Abstract	10-005 - Downbeat Nystagmus in Patient with AQP4-positive Neuromyelitis Optica Isabella Canut
08:00 AM - 09:00 AM MDT	Abstract	10-006 - Isolated Downgaze Palsy in a Patient with Acute Pretectum Paramedian Midbrain and Left Thalamic Ischemic Infarctions: A Case Report JoBeth D. Bingham, DO
08:00 AM - 09:00 AM MDT	Abstract	4-001 - The First Report of Myoclonus and Putaminal Cysts in Salla Disease—The Phenotype Expanded Esther Macken, MD
08:00 AM - 09:00 AM MDT	Abstract	4-002 - Expounding a Rare Association Between Motor Neuron Disease and Parkinson-Plus Syndromes Jason Gandhi, MD
08:00 AM - 09:00 AM MDT	Abstract	4-003 - Superficial Siderosis of the Central Nervous System (SS-CNS): A Mimic of Motor Neurone Disease Esther Macken, MD
08:00 AM - 09:00 AM MDT	Abstract	4-004 - Neurologic Involvement in Cystinosis: Focus on Brain Lesions and New Evidence of Four-repeat (4R-) Tauopathy Tommaso Nicoletti, MD
08:00 AM - 09:00 AM MDT	Abstract	4-005 - Provider “B”-ware: Using Methylmalonic Acid Levels to Diagnose B12-deficiency Neuropathy Sahil Naik, MD
08:00 AM - 09:00 AM MDT	Abstract	4-006 - A Hard Pill to Swallow, Cenobamate-induced Neutrophilic Dermatoses Misdiagnosed as Neuro-sweet Syndrome Maria Belen Solis Mayorga, MD
08:00 AM - 09:00 AM MDT	Abstract	4-007 - Acute Idiopathic Syringomyelia Ghazal Ahmad, MD
08:00 AM - 09:00 AM MDT	Abstract	4-008 - Glioblastoma Chameleons: A Case Series of Sudden Onset Aphasia and Alexia Without Agraphia Secondary to Complications of Glioblastoma Initially Mimicking Stroke Shuodan Zhang, MD
08:00 AM - 09:00 AM MDT	Abstract	4-009 - Evaluation of Copy Number Losses in the MBD5 5’-Untranslated Region: Expression Matters Karishma Kashyap
08:00 AM - 09:00 AM MDT	Abstract	4-010 - Delayed Progressive Leukoencephalopathy and Rash in a Patient with Cocaine Use Melanie Li, MD
08:00 AM - 09:00 AM MDT	Abstract	4-011 - Peripheral Neural Correlates of Isolated Genital Numbness Sarah Wright, PhD, MBChB
08:00 AM - 09:00 AM MDT	Abstract	4-012 - Non-traumatic Cause of Brown-Sequard Syndrome: a Case Report Rania Issa, MD
08:00 AM - 09:00 AM MDT	Abstract	4-013 - Remarkable Improvement of Initially Devastating Post-SARS-CoV-2 Myelitis After Administration of Steroids and Plasmapheresis Amra Sakusic, MD
08:00 AM - 09:00 AM MDT	Abstract	13-001 - Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Anti-nerve Growth Factor (NGF) Antibody Tanezumab in Subjects with Moderate to Severe Pain Due to Schwannomatosis Danielle Silverman
08:00 AM - 09:00 AM MDT	Abstract	13-004 - Unraveling the Triple Helix of Spine Pain: Spine Pain Diagnosis Rates Correlate with At-level Degenerative Spinal Condition Diagnoses Suraj Malhan, DO
08:00 AM - 09:00 AM MDT	Abstract	13-008 - The Efficacy of Fibrolux Laser Therapy in Fibromyalgia Wael Richeh, MD
08:00 AM - 09:00 AM MDT	Abstract	13-009 - An Unusual Presentation of Meningitis Lucy Gee, PhD
08:00 AM - 09:00 AM MDT	Abstract	13-010 - Is it Really a Stroke? Cervical Spinal Abscess Presenting with Unilateral Weakness Nezar Khatib, MD
08:00 AM - 09:00 AM MDT	Abstract	5-001 - Meningiomatosis in a Patient with Cornelia de Lange Syndrome: A Case Study Jessica White, MD
08:00 AM - 09:00 AM MDT	Abstract	5-002 - Triple Century in a Century (Lhermitte–Duclos Disease) -The Tale of a CNS Tumor Aparna Kalyani Pariyadath, MBBS
08:00 AM - 09:00 AM MDT	Abstract	5-003 - Double Trouble: Rare Multiple Femoral Nerve Schwannomma and Peripheral Neuropathy Respond to Immunosuppression in a Patient with Neurofibromatosis Type 2 Lydia Kauffman, MD
08:00 AM - 09:00 AM MDT	Abstract	5-004 - Cough-headache as a Novel Presentation of Methotrexate Neurotoxicity Philion Gatchoff, MD
08:00 AM - 09:00 AM MDT	Abstract	5-005 - Optic Neuritis in a Case of Secondary Hemophagocytic Lymphohistocytosis Priscilla Yan, MD
08:00 AM - 09:00 AM MDT	Abstract	5-006 - An Unusual Case of Transverse Myelitis After Anti-CD19 CAR T Cell Therapy for a Patient with Diffuse Large B Cell Lymphoma Hadi M. Mohammad Khanli, MD
08:00 AM - 09:00 AM MDT	Abstract	5-007 - A Rare RASopathy: Neurofibromatosis Noonan Syndrome Amber R. Hughes
08:00 AM - 09:00 AM MDT	Abstract	5-008 - Unraveling the Diagnosis and Therapeutic Triumph in Intravascular CNS Lymphoma: A Case Report Kajol H. Doshi, MD
08:00 AM - 09:00 AM MDT	Abstract	5-009 - Angioimmunoblastic T Cell Lymphoma Presenting as Subacute Sensorimotor Peripheral Neuropathy Nicholas J. Bellacicco, DO
08:00 AM - 09:00 AM MDT	Abstract	5-011 - Identifying a Relationship Between Executive Dysfunction, Poor Sleep Hygiene/Sleep Apnea, and Ventriculomegaly in Cancer-related Cognitive Impairment (CRCI) Rhonna S. Shatz, DO
08:00 AM - 09:00 AM MDT	Abstract	5-012 - Intracerebral Hemorrhage Risk in Patients with Primary Brain Tumors Taking Direct Oral Anticoagulants as Compared with Low Molecular Weight Heparin Surabhi Ranjan, MD
08:00 AM - 09:00 AM MDT	Abstract	5-013 - Examining Rates of Pseudoprogression in Older Patients with Glioblastoma Derek L. Chien
08:00 AM - 09:00 AM MDT	Abstract	5-014 - Medical Comorbidities as Predictors of Survival in Glioblastoma Justin D. Bessette
08:00 AM - 09:00 AM MDT	Abstract	5-015 - The Effect of Various Tumor Characteristics on Symptoms Experienced by Glioblastoma Patients Sreya Devarakonda
08:00 AM - 09:00 AM MDT	Abstract	5-016 - A Prospective Cohort Study to Evaluate the Natural History of and Identify Risk Factors for the Development of Tumor-related Epilepsy (TRE) Thomas Wychowski, MD
08:00 AM - 09:00 AM MDT	Abstract	5-017 - Metabolic Risk Factors and Outcomes in Patients with Glioblastoma Orwa Aboud, MD, PhD
08:00 AM - 09:00 AM MDT	Abstract	5-018 - Depression as Primary Symptom Presentation of Glioblastoma Multiforme: A Case Series Jordanne Kirschke
08:00 AM - 09:00 AM MDT	Abstract	5-019 - Strokes in Individuals with Primary Brain Glioma After Radiation Therapy Managed with Bevacizumab: A Subgroup Analysis of a Retrospective Cohort Dylan T. Ryan, MD
08:00 AM - 09:00 AM MDT	Abstract	5-020 - The Effect of Social Demographics on Optune Usage Amongst Patients with Glioblastoma Sreya Devarakonda
08:00 AM - 09:00 AM MDT	Abstract	5-021 - An Illustrative Case of Daratumumab-associated Leukoencephalopathy: A Rare but Important Complication of Anti-CD38 Therapy in Multiple Myeloma Patients Dan Tong Jia, MD
08:00 AM - 09:00 AM MDT	Abstract	5-022 - Managing Neurotoxicity in B-cell Maturation Antigen (BCMA)-directed Therapy: A Case-series Study Ambar M. MORALES-RODRIGUEZ, MD
08:00 AM - 09:00 AM MDT	Abstract	5-023 - An Interesting Presentation of a Blinatumomab-associated Neurological Event Shivika Chandra, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	5-024 - Routine Cancer Imaging Detects Risk of Metastatic Spinal Cord Compression and Time to Fracture My H. Nguyen
08:00 AM - 09:00 AM MDT	Abstract	5-025 - Serum Neurofilament Light Chain (sNfL) as Potential Biomarker for Immune Check Point Inhibitor (ICI) Mediated Limbic Encephalitis – A Case Series Anza Zahid, MD, MBBS
08:00 AM - 09:00 AM MDT	Abstract	5-027 - Rapidly Progressive Dementia and Extrapyramidal Symptoms Associated with Froin’s Syndrome due to Leptomeningeal Carcinomatosis Neil R. Holland, MBBS, FAAN
08:00 AM - 09:00 AM MDT	Abstract	5-028 - A Case of Primary Intracranial Spindle Cell Carcinoma with DICER-1 Mutation Presenting as Abnormal Leptomeningeal Enhancement in an Immunocompetent Patient Bavica Gummadi, DO
08:00 AM - 09:00 AM MDT	Abstract	5-029 - Chronic Myelomonocytic Leukemia (CMML) Presenting with Numb Chin Syndrome and Intractable Headache Saori L. Haigo, MD, PhD
08:00 AM - 09:00 AM MDT	Abstract	5-030 - A Case of Reversible Cerebral Vasoconstriction Syndrome (RCVS) After Axitinib and Pembrolizumab Therapy Saif S. Bawaneh, MD
08:00 AM - 09:00 AM MDT	Abstract	5-031 - Cryptococcal Meningitis Misdiagnosed as Leptomeningeal Disease (LMD): A Case Series Rutu Patel, PA
08:00 AM - 09:00 AM MDT	Abstract	5-032 - Extracranial Metastases from High-grade Glioma – Two Case Reports Jay-Jiguang Zhu, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	2-001 - Can Clinical Scores Predict the Presence of Hypoxic Ischemic Brain Injury on Early Head Computed Tomography After Cardiac Arrest? Christine Nguyen
08:00 AM - 09:00 AM MDT	Abstract	2-003 - Synthetic Fentanyl and Xylazine—The New Rogue Wave of the Opioid Crisis: A Neuroimaging Case Series of “Tranq-Dope” Overdoses Nirmala Ghimirey, DO
08:00 AM - 09:00 AM MDT	Abstract	2-004 - Treatment and Long-term Outcome of Lance-Adams Syndrome Helena Xeros, MD
08:00 AM - 09:00 AM MDT	Abstract	2-005 - Patterns of Cerebral Hemodynamic Changes After Out of Hospital Cardiac Arrest May Zin Myint, MBBS
08:00 AM - 09:00 AM MDT	Abstract	2-006 - Neurological Prognostication in Post-cardiac Arrest Patients: A Systematic Review Yugant Khand, MBBS, DiMM
08:00 AM - 09:00 AM MDT	Abstract	11-001 - Improving Measurement of Lung Function in ALS: The Results of the Pulmonary Function via Impedance Tomography (PuFIT) Study Seward B. Rutkove, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	11-002 - Early Gastrostomy Versus Late Gastrostomy Tube Performed in ALS Patients Admitted with Aspiration Pneumonia in the United States Baljinder Singh, MD
08:00 AM - 09:00 AM MDT	Abstract	11-003 - Machine-learning Techniques Applied to F-wave Waveforms Can Predict the Likelihood and Survival of ALS Patients Kevin A. Mazurek, PhD
08:00 AM - 09:00 AM MDT	Abstract	11-004 - Sex-related Differences in ALS Survival and Progression: Insights from a Population-based Study Maurizio Grassano, MD
08:00 AM - 09:00 AM MDT	Abstract	11-005 - Upper Motor Neuron Involvement Examined by Triple Stimulation in Amyotrophic Lateral Sclerosis Christian Krarup, MD, DMSc, FRcP, FAAN
08:00 AM - 09:00 AM MDT	Abstract	11-006 - Use High-dimensional Immune Profiling to Study Peripheral Immune System and ALS Progression Xiaoyan Li, MD
08:00 AM - 09:00 AM MDT	Abstract	11-007 - Retrospective Observational Study of ALS-associated Genes and Their Variants Pardis Pooshpas, MD
08:00 AM - 09:00 AM MDT	Abstract	11-009 - Neurofilaments in Amyotrophic Lateral Sclerosis: A Systemic Review and Meta-analysis Pashtun-Poh Shahim, MD, PhD
08:00 AM - 09:00 AM MDT	Abstract	11-010 - QRL-201-01—A Multi-center, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of QRL-201 in Amyotrophic Lateral Sclerosis Angela L. Genge, MD
08:00 AM - 09:00 AM MDT	Abstract	11-011 - Characterizing Patient Preferences, Satisfaction, and Quality of Care Across Health Care Models in Amyotrophic Lateral Sclerosis (ALS) Ilene Hollin
08:00 AM - 09:00 AM MDT	Abstract	11-013 - Internet-supervised Home-based Spirometry Through Telemedicine in Amyotrophic Lateral Sclerosis Eufrosina I. Young, MD
08:00 AM - 09:00 AM MDT	Abstract	11-014 - Brief Report on Juvenile Amyotrophic Lateral Sclerosis Cases in the United State National ALS Registry: 2010–2018 Moon Han, PhD
08:00 AM - 09:00 AM MDT	Abstract	11-015 - Geographic Distribution of Amyotrophic Lateral Sclerosis (ALS) in the Chicagoland Area Abeeha Mirza
08:00 AM - 09:00 AM MDT	Abstract	11-016 - Amyotrophic Lateral Sclerosis (ALS) in Puerto Rico: An Overview Frances M. Aponte-Caraballo, MS
08:00 AM - 09:00 AM MDT	Abstract	11-017 - Chlorovirus Glycoproteins and SOD1G93A Significantly Enhance, While Cellular Proteins IRF3 and ERK MAP-kinase Significantly Dampen, Production of ALS-associated Inflammatory Factors from Murine Macrophages Gary L. Pattee, MD
08:00 AM - 09:00 AM MDT	Abstract	11-018 - Validating a Novel CSF-mediated Animal Model of Sporadic ALS Sarah M. Kovalev, RA
08:00 AM - 09:00 AM MDT	Abstract	11-019 - Evaluating the Safety, Tolerability, and Pharmacokinetics of QRL-101 in Two Phase 1 Studies: QRL-101-01 in Healthy Adults and QRL-101-02 in Adults with ALS Angela L. Genge, MD
08:00 AM - 09:00 AM MDT	Abstract	11-020 - The Use of Relyvrio in ALS Among General Neurologists Compared to Neuromuscular Specialists and to ALS Center Affiliated Neurologists Blaine Cloud, PhD
08:00 AM - 09:00 AM MDT	Abstract	14-001 - A Case of Thymoma-associated Paraneoplastic Encephalitis with Identification of a Novel Neuronal Antibody Alexa L. Carreras, MD
08:00 AM - 09:00 AM MDT	Abstract	14-002 - Long-lived Plasma Cells Associated with Relapsing Anti-NMDAR Encephalitis Yue Liu
08:00 AM - 09:00 AM MDT	Abstract	14-003 - Proteome Remodeling in a Peptide Immunization Animal Model of Anti-NMDAR Encephalitis David R. Benavides, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	14-004 - Autonomic Dysfunction in Autoimmune Encephalitis: A Review of the Literature Sophie Ohrn
08:00 AM - 09:00 AM MDT	Abstract	14-005 - Treatment of Refractory Anti-NMDA Receptor Encephalitis with Daratumumab in Two Pediatric Patients Amy Young, MD
08:00 AM - 09:00 AM MDT	Abstract	14-006 - ECT in NMDAR Encephalitis: A Retrospective Cohort and Systematic Review of Literature Melissa A. Wright, MD
08:00 AM - 09:00 AM MDT	Abstract	14-007 - Characterization of Social Determinants of Health in Patients with Anti-NMDAR Encephalitis Ka-Ho Wong
08:00 AM - 09:00 AM MDT	Abstract	14-008 - Efficacy and Safety of Different Oral Prednisone Tapering Course in Anti-N-M-methyl-D-aspartate Receptor Encephalitis: A Multicenter Cohort Study Linjun Cai, PhD
08:00 AM - 09:00 AM MDT	Abstract	14-010 - Acute Autoimmune Limbic Encephalitis Associated with GABABR Antibody in a Patient with Advanced Squamous Cell Carcinoma of the Cervix Treated with Pembrolizumab: A Case Report Shiv K. Jha, MBBS
08:00 AM - 09:00 AM MDT	Abstract	14-011 - The Use of APE2 Score to Diagnose Autoimmune Encephalitis Bijoya Basu
08:00 AM - 09:00 AM MDT	Abstract	14-012 - Anti GABA-B Receptor Autoimmune Encephalitis Associated with Thymoma: Case Report Reena Bastin, MD
08:00 AM - 09:00 AM MDT	Abstract	14-013 - NMDA Receptor Encephalitis in a Transgender Patient: A Case Report and Literature Review Christina Law, MD, MEd
08:00 AM - 09:00 AM MDT	Abstract	14-014 - Non-convulsive Status Epilepticus due to LGI-1 Encephalitis Presenting as Intermittent Confusion Hiromi Terai
08:00 AM - 09:00 AM MDT	Abstract	14-015 - AMPA Receptor Encephalitis: A Decade-long Unveiling of Clinical, Radiographic, and Serological Findings in an Untreated Patient Ahmad Mahadeen, MD
08:00 AM - 09:00 AM MDT	Abstract	14-016 - Autoimmune Limbic Encephalitis in the Setting of TNF-Inhibitor Use for Crohn’s Disease Zainab Al Obaidi, MD
08:00 AM - 09:00 AM MDT	Abstract	14-017 - Case of Late Recurrence of Leucine-rich Glioma Inactivated-1 Protein IgG (LGI-1) Encephalitis: Highlighting Nuances of Long-term Medical Management of Autoimmune Antibody-mediated Encephalitis Hannah Harrison, MD, MBA
08:00 AM - 09:00 AM MDT	Abstract	14-018 - Late-onset Anti-NMDAr Encephalitis After HSV Encephalitis in Pregnancy Ann Zheng, MD
08:00 AM - 09:00 AM MDT	Abstract	14-019 - Case of LGI-1 Associated Encephalitis Presenting as Isolated Asymmetric Chorea Meenakshi Roy, MD
08:00 AM - 09:00 AM MDT	Abstract	14-020 - Initial MRI, EEG, and CSF White Cell Count Are Abnormal in Children with Anti-NMDA Receptor Encephalitis with Isolated Psychiatric Symptoms Grace Gombolay, MD, FAAN
08:00 AM - 09:00 AM MDT	Abstract	8-001 - Systemic Complications and Natural History of Aicardi Goutières Syndrome Amanda Jan
08:00 AM - 09:00 AM MDT	Abstract	8-002 - Diagnostic Journey and Therapeutic Intervention of a Type-1 Interferonopathy in a Newborn Marie Varnet, MD
08:00 AM - 09:00 AM MDT	Abstract	8-003 - Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis Monica Margoni
08:00 AM - 09:00 AM MDT	Abstract	8-004 - Anti-NMDA Encephalitis Co-positive with Aquaporin 4 Antibodies in a 4-year-old Female Chloe LaRochelle, MD
08:00 AM - 09:00 AM MDT	Abstract	8-005 - Pediatric Seronegative NMOSD: A Case Series and Literature Review Madison M. Patrick
08:00 AM - 09:00 AM MDT	Abstract	8-006 - Diagnostic and Immunological Features of Post-Covid-19 Postural Orthostatic Tachycardia Syndrome in Children Jinny O. Tavee, MD
08:00 AM - 09:00 AM MDT	Abstract	8-007 - Safety and Tolerability of Intravenous Immunoglobulin Infusion in Down Syndrome Regression Disorder Jonathan Santoro, MD
08:00 AM - 09:00 AM MDT	Abstract	8-008 - A Case Report of Rapidly Fatal MOG Antibody-associated ADEM in a Pediatric Patient Emily Allen

Faculty Disclosures
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN	An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Henry L. Paulson, MD, PhD, FAAN	Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Steven Frucht, MD	Dr. Frucht has nothing to disclose.
Kathleen M. Shannon, MD, FAAN	The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Jose Biller, MD, FACP, FAHA, FAAN	Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Stewart J. Tepper, MD	Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical ��ɫ�� Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' ��ɫ�� Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical ��ɫ��. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research ��ɫ�� Social Awareness and Training In Neurosciences.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Samuel Wiebe, MD	Dr. Wiebe has a non-compensated relationship as a Past President with International League Against Epilepsy that is relevant to AAN interests or activities.
Gary L. Pattee, MD	The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
Karen S. Marder, MD, MPH, FAAN	Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Phillip A. Low, MD, FAAN	Dr. Low has nothing to disclose.
Eelco F. Wijdicks, MD, FAAN	Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Stephen P. Salloway, MD, MS	Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NovoNordisk. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurophet. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kisbee. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CognitionRX. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck.
Kenneth H. Fischbeck, MD, FAAN	Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Rhonna S. Shatz, DO	Dr. Shatz has nothing to disclose.
Douglas J. Lanska, MD, FAAN	Dr. Lanska has received personal compensation for serving as an employee of Ministry of Health of the Russian Federation. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedScape ��ɫ��. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebix/Oakstone Publishing. Dr. Lanska has received publishing royalties from a publication relating to health care. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Mayo Clinic.
Elijah Stommel, MD, FAAN	Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
Romergryko G. Geocadin, MD, FAAN	Dr. Geocadin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Consulting.
Stefan M. Pulst, MD, FAAN	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Michael A. Rogawski, MD, PhD	Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
James J. Riviello, Jr., MD	Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Scott S. Zamvil, MD, PhD, FAAN	Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
David H. Margolin, MD, PhD	Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Andrew S. Feigin, MD	Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Anne H. Cross, MD, FAAN	Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Helmi L. Lutsep, MD, FAAN	Dr. Lutsep has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lutsep has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Coherex Medical. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/Mayo Cinic. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape Neurology.
Eduardo E. Benarroch, MD, FAAN	Dr. Benarroch has nothing to disclose.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Howard A. Crystal, MD, FAAN	An immediate family member of Dr. Crystal has received personal compensation for serving as an employee of C4 TherAPEUTICS. An immediate family member of Dr. Crystal has stock in c4 THERAPEUTICS. Dr. Crystal has stock in c4 THERAPEUTICS.
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Peter H. St George-Hyslop, MD, PhD	Dr. St George-Hyslop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TransitionBio. The institution of Dr. St George-Hyslop has received research support from NIH. Dr. St George-Hyslop has received intellectual property interests from a discovery or technology relating to health care.
Sudha Kessler, MD	Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Efficient CME. Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. The institution of Dr. Kessler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Kessler has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson, Elser. The institution of Dr. Kessler has received research support from FDA, Commonwealth of Pennsylvania, Epilepsy Study Consortium, UCB Pharma, Greenwich Biosciences, Eisai Co. Ltd.. PCORI/AHRQ, SK Life. Dr. Kessler has a non-compensated relationship as a volunteer committee member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Kessler has a non-compensated relationship as a committee member with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Sarah H. Ying, MD	Dr. Ying has nothing to disclose.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Jennifer J. Majersik, MD, FAAN	Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Manjari Tripathi, MD	Dr. Tripathi has nothing to disclose.
Adeline Vanderver, MD, FAAN	An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Mandy Koop	No disclosure on file
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Wolfgang Singer, MD, FAAN	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Ari Green, MD	Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
Jeffery Vance, MD, PhD	Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Dennis W. Dickson, MD	Dr. Dickson has nothing to disclose.
Janet C. Rucker, MD	Dr. Rucker has nothing to disclose.
Luanne Metz, MD	The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Albert Lo, MD, PhD	No disclosure on file
Ian Miller, MD	Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
Jorge C. Kattah, MD, FAAN	Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Michael J. Schneck, MD, FAAN	An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
David K. Urion, MD, FAAN	Dr. Urion has nothing to disclose.
Sachin Kedar, MD, FAAN	Dr. Kedar has nothing to disclose.
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Erin Furr-Stimming, MD, FAAN	Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from HDSA. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
Jane S. Paulsen, PhD	Dr. Paulsen has received personal compensation in the range of $0-$499 for serving as a Consultant for CHDI. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for HDSA. The institution of Dr. Paulsen has received research support from NIH/NIA. The institution of Dr. Paulsen has received research support from NIH/NINDS.
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Manikum Moodley, MD, FAAN	Dr. Moodley has nothing to disclose.
Giacomo Koch	No disclosure on file
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Franck Durif, MD, PhD	No disclosure on file
Cristina Moglia	Cristina Moglia has nothing to disclose.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Zhen Hong, MD	No disclosure on file
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Giuseppe Lanzino, MD	Dr. Lanzino has nothing to disclose.
Marc Weisskopf, PhD	Prof. Weisskopf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaiser Permanente Research Biobank. The institution of Prof. Weisskopf has received research support from ALS Network. The institution of Prof. Weisskopf has received research support from NIH. The institution of Prof. Weisskopf has received research support from Paralyzed Veterans of America. The institution of Prof. Weisskopf has received research support from CDC/ATSDR. The institution of Prof. Weisskopf has received research support from JPB Foundation.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
	No disclosure on file
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Masatoyo Nishizawa, MD	No disclosure on file
Ping Zhuang, PhD	Dr. Zhuang has nothing to disclose.
Susan L. Perlman, MD	Dr. Perlman has nothing to disclose.
Beth B. Hogans, MD, PhD	Dr. Hogans has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Pain Medicine. The institution of Dr. Hogans has received research support from VA Office of Research and Development. Dr. Hogans has received intellectual property interests from a discovery or technology relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has a non-compensated relationship as a Grant reviewer with Veterans Affairs Office of Research and Development that is relevant to AAN interests or activities. Dr. Hogans has a non-compensated relationship as a Grant reviewer with National Institutes of Health that is relevant to AAN interests or activities.
Laurent Servais	Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Kenshi Terajima, MD, PhD	No disclosure on file
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Fortunato Battaglia, MD	Dr. Battaglia has nothing to disclose.
Sudha Seshadri, MD, FAAN	Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Yazmin Odia, MD, MS, MBA, FAAN	Dr. Odia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimeric, part of Jazz Pharmaceuticals.
Stephan Zuchner, MD, FAAN	Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Galina Vorobeychik, MD, FRCPC, FAAN	Dr. Vorobeychik has nothing to disclose.
Ryuji Kaji, MD, FAAN	Dr. Kaji has nothing to disclose.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Virender Bhan, MD	Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Timothy R. Smith, MD	The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
John Sorkin	No disclosure on file
Florian P. Thomas, MD, PhD, MA, FAAN	Dr. Thomas has received personal compensation for serving as an employee of Hackensack Meridian Health. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MND. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Spinal Cord Medicine. Dr. Thomas has a non-compensated relationship as a Board Member, Metro New Jersey with National MS Society that is relevant to AAN interests or activities. Dr. Thomas has a non-compensated relationship as a Board Member with American Paraplegia Society that is relevant to AAN interests or activities.
Finn Sellebjerg, MD	Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Mustapha A. Danesi, MD	No disclosure on file
Njide Okubadejo, MD, FAAN	The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Francis I. Ojini, MD	No disclosure on file
Neil R. Holland, MBBS, FAAN	Dr. Holland has nothing to disclose.
Michael McDermott	No disclosure on file
Joanne Wuu, SCM	The institution of Ms. Wuu has received research support from NIH NINDS. The institution of Ms. Wuu has received research support from NIH NCATS/NINDS. The institution of Ms. Wuu has received research support from CDC. The institution of Ms. Wuu has received research support from Target ALS. The institution of Ms. Wuu has received research support from ALS Recovery Fund. The institution of Ms. Wuu has received research support from NIH/NINDS. The institution of Ms. Wuu has received research support from NIH NINDS. The institution of an immediate family member of Ms. Wuu has received research support from NIH NINDS.
Jennifer Whitwell, PhD	The institution of Dr. Whitwell has received research support from NIH.
Maha Alattar, MD	Dr. Alattar has nothing to disclose.
Sarah J. Tabrizi, MD, PhD	Sarah J. Tabrizi, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for F. Hoffmann-La Roche Ltd. Sarah J. Tabrizi, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Thomas A. Berger, MD	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Suman Jayadev, MD	Dr. Jayadev has nothing to disclose.
Terry D. Heiman-Patterson, MD	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Deanna Saylor, MD, MHS, FAAN	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from ��ɫ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and ��ɫ��al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Kaj Blennow	Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Maryann Mays, MD, FAAN	Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
Eric T. Wong, MD, FAAN	Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Cathra Halabi, MD	The institution of Dr. Halabi has received research support from UC Noyce Initiative. The institution of Dr. Halabi has received research support from Weill Institute for Neurosciences Neurohub. The institution of Dr. Halabi has received research support from NIH/NIDCD. The institution of Dr. Halabi has received research support from NIH/StrokeNet. Dr. Halabi has a non-compensated relationship as a Working Group Member with National Academies of Sciences, Engineering, and Medicine Action Collaborative on TBI Care that is relevant to AAN interests or activities. Dr. Halabi has a non-compensated relationship as a Working Group Member with NIH/StrokeNet Recovery and Rehabilitation Working Group that is relevant to AAN interests or activities.
Jerome J. Graber, MD, MPH, FAAN	Dr. Graber has received personal compensation for serving as an employee of Binaytara Foundation. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ��. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurological Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with ��ɫ�� that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Ashis H. Tayal, MD	Dr. Tayal has nothing to disclose.
Peter J. McAllister, MD, FAAN	Dr. McAllister has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for pfizer. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Michael Strupp, MD, DO, FAAN	Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has or had stock in IntraBio.
Lucas Restrepo, MD, PhD	Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
James Marriott, MD, MSc	Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Marriott has received research support from Sanofi. The institution of Dr. Marriott has received research support from Roche. The institution of Dr. Marriott has received research support from Novartis.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Margaret A. Pericak-Vance, PhD	Dr. Pericak-Vance has nothing to disclose.
Samuel A. Frank, MD, FAAN	Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel.
Michael G. Benatar, MBChB, DPhil, FAAN	Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Rajeev Kumar, MD, FRCPC	The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevance. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ferrer. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. Dr. Kumar has stock in Neurofold Therapeutics. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. The institution of Dr. Kumar has received research support from Aribio. The institution of Dr. Kumar has received research support from Biogen. The institution of Dr. Kumar has received research support from Bial R and D investments. The institution of Dr. Kumar has received research support from Ono Pharmaceutical Company. The institution of Dr. Kumar has received research support from UCB Biopharma. The institution of Dr. Kumar has received research support from Vigil Therapeutics. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC. Dr. Kumar has a non-compensated relationship as a Board Member with Movement Disorders Foundation that is relevant to AAN interests or activities.
Pierre Duquette, MD	The institution of Dr. Duquette has received research support from Biogen and Genzyme.
Simon Cronin, PhD	Prof. Cronin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Stanley J. Iyadurai, MD, PhD, FAAN	Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Francois Grand-Maison, MD	Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis .
Matthew J. Thurtell, MD	Dr. Thurtell has received publishing royalties from a publication relating to health care.
Bernard Brais, MD	Dr. Brais has nothing to disclose.
Gerald Raymond, MD	Dr. Raymond has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bluebird bio. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere. Dr. Raymond has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Dept of HHS.
Marcelo C. Kremenchutzky, MD, FAAN	No disclosure on file
Tracey A. Milligan, MD, FAAN	Dr. Milligan has received publishing royalties from a publication relating to health care.
Michael S. Rafii, MD, PhD	Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Rafii has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Keystone Bio. Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon.
Christian Krarup, MD, DMSc, FRcP, FAAN	Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Michael R. Sorrell, MD, FAAN	Dr. Sorrell has nothing to disclose.
Eduardo R. Locatelli, MD	An immediate family member of Dr. Locatelli has received personal compensation for serving as an employee of Pfizer. The institution of Dr. Locatelli has received research support from ALS association. The institution of Dr. Locatelli has received research support from Department of Defense.
Gregg G. Blevins, MD, FRCP(C)	Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-roche. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. The institution of Dr. Blevins has received research support from Novartis. Dr. Blevins has received research support from Hoffman La-Roche. The institution of Dr. Blevins has received research support from EMD Serono. Dr. Blevins has received research support from Biogen Idec. The institution of Dr. Blevins has received research support from MS society of Canada. The institution of Dr. Blevins has received research support from Canadian Institutes of Health Research .
Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN	Dr. Ritzl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Ritzl has a non-compensated relationship as a Advocacy committee co-chair and CPT and RUC representation with ACNS that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Health Policy committee member with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a AAN HOD Alternate Delegate with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Epic Neurosciences steering board with Epic that is relevant to AAN interests or activities.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Masato Kanazawa, MD, FAAN	Dr. Kanazawa has nothing to disclose.
Katherine Carroll, MD	Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Lara V. Marcuse, Sr., MD	Dr. Marcuse has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace.
Elizabeth H. Morrison-Banks, MD, MSEd	Dr. Morrison-Banks has nothing to disclose.
Cristina Granziera, MD, PhD	The institution of Prof. Granziera has received research support from Novartis. The institution of Prof. Granziera has received research support from Hoffmann La Roche. The institution of Prof. Granziera has received research support from Genzyme Sanofi. The institution of Prof. Granziera has received research support from Biogen.
Maarten J. Titulaer, MD, PhD	The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received intellectual property interests from a discovery or technology relating to health care. Dr. Titulaer has received publishing royalties from a publication relating to health care.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Marie-Josee Dicaire	Marie-Josee Dicaire has nothing to disclose.
Grace Gombolay, MD, FAAN	The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH. Dr. Gombolay has a non-compensated relationship as a Board of Trustee with National MS Society -Georgia chapter that is relevant to AAN interests or activities.
Ihab Hajjar	Ihab Hajjar has nothing to disclose.
Tibor Hortobagyi	No disclosure on file
Bijen Nazliel	No disclosure on file
Mehmet Yaman, MD	No disclosure on file
Henrik Zetterberg	Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Nathan P. Staff, MD, PhD, FAAN	Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Christopher Gomez, MD, PhD	Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Piera Pasinelli	The institution of Dr. Pasinelli has received research support from NIH-NINDS.
Vikram Shakkottai, MD, PhD	The institution of Dr. Shakkottai has received research support from National Institutes of Health. Dr. Shakkottai has received publishing royalties from a publication relating to health care.
Sarah E. Schmitt, MD, FAAN	Dr. Schmitt has a non-compensated relationship as a President with American Board of Registered EEG Technologists -- LTM board that is relevant to AAN interests or activities.
MaryLynn Chu, MD	Dr. Chu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics; PTC Therapeutics,Inc..
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Sudhakar Tummala, MD, FAAN	Dr. Tummala has nothing to disclose.
Florian Deisenhammer, MD	Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Deisenhammer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SOBI.
Michael J. Marmura, MD, FAAN	Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. The institution of Dr. Marmura has received research support from Axsome. The institution of Dr. Marmura has received research support from Pfizer. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Merry Chen, MD	Dr. Chen has nothing to disclose.
Sashank Prasad, MD	Dr. Prasad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medicolegal firms. Dr. Prasad has received publishing royalties from a publication relating to health care.
Phyllis Faust	Phyllis Faust has nothing to disclose.
Daniel Pastula, MD, MHS, FAAN	Dr. Pastula has nothing to disclose.
Joanna E. Bielewicz, PhD	Dr. Bielewicz has nothing to disclose.
Natalia Pessoa Rocha	Natalia Pessoa Rocha has nothing to disclose.
Alona Muzikansky	No disclosure on file
Andrew Bauerschmidt, MD	Dr. Bauerschmidt has nothing to disclose.
Sanjay Mittal, MD	Dr. Mittal has nothing to disclose.
Sarlota Mesaros	Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Hemofarm. Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Miya Bernson-Leung, MD, FAAN	An immediate family member of Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioMarin. Dr. Bernson-Leung has stock in Abbott Labs. Dr. Bernson-Leung has stock in Abbvie Inc.
Wael Richeh, MD	Dr. Richeh has nothing to disclose.
Carlo Rinaldi, MD, PhD	No disclosure on file
Jose Gutierrez, MD	Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Katherine B. Peters, MD, PhD, FAAN	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals/Deciphera. The institution of Dr. Peters has received research support from Nuvation. The institution of Dr. Peters has received research support from Novocure. The institution of Dr. Peters has received research support from Curis.
Brian Sweeney, MD	No disclosure on file
Rebecca Romero, MD, FAAN	Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Claire Creutzfeldt, MD	The institution of Dr. Creutzfeldt has received research support from NINR. The institution of Dr. Creutzfeldt has received research support from NIA.
Peggy Auinger	Ms. Auinger has nothing to disclose.
Gary W. Beecham, PhD	The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
Danny Bega, MD	Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SOM. Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Mark Gorman, MD	The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Mohankumar Kurukumbi, MD	Dr. Kurukumbi has nothing to disclose.
Max R. Lowden, MD, FAAN	Dr. Lowden has nothing to disclose.
Letizia Mazzini	No disclosure on file
Glenn Morrison, PhD	Dr. Morrison has received personal compensation for serving as an employee of Alector. Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG . Dr. Morrison has stock in Alector. Dr. Morrison has received intellectual property interests from a discovery or technology relating to health care.
Fabricio F. De Oliveira, MD, PhD, BBA, MSc, FAAN	Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gerson Lehrman Group. Dr. De Oliveira has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Atheneum Partners. Dr. De Oliveira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lionbridge. Dr. De Oliveira has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman. Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. De Oliveira has received personal compensation in the range of $0-$499 for serving as a Neurology® Video Journal Club Presenter with ��ɫ��.
Joshua Tobin, MD, FAAN	An immediate family member of Dr. Tobin has received personal compensation for serving as an employee of Amgen. Dr. Tobin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tobin has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie.
Vincent Van Pesch, MD, PhD	Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Vincent Van Pesch, MD, PhD has received research support from Biogen.
Deepti Vibha, MD	Dr. Vibha has nothing to disclose.
George R. Wilmot, MD, PhD	Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.
Nassim Zecavati, MD, FAAN	Dr. Zecavati has nothing to disclose.
Lorne H. Zinman, MD	Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Shan E. Abbas, MD	Dr. Abbas has nothing to disclose.
Christopher Grunseich, MD	The institution of Dr. Grunseich has received research support from AnnJi Pharmaceuticals.
Costantino Iadecola, MD	Dr. Iadecola has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Broadview Ventures.
Michael S. Jaffee, MD, FAAN	Dr. Jaffee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society / New England Journal of Medicine Group. Dr. Jaffee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for McDermott, Will, and Emery on behalf of NCAA. The institution of Dr. Jaffee has received research support from NIH. Dr. Jaffee has received personal compensation in the range of $10,000-$49,999 for serving as a Director with American Board of Psychiatry and Neurology. Dr. Jaffee has received personal compensation in the range of $5,000-$9,999 for serving as a DoD study section member with Leidos in support of CDMRP.
Jay L. Alberts, PhD	Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceraxis. Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceraxis. The institution of Dr. Alberts has received research support from NIH. The institution of Dr. Alberts has received research support from Department of Defense. The institution of Dr. Alberts has received research support from Michael J. Fox Foundation. Dr. Alberts has received intellectual property interests from a discovery or technology relating to health care. Dr. Alberts has received personal compensation in the range of $500-$4,999 for serving as a Member, Health and Wellness Council with Peloton Interactive.
Roumen D. Balabanov, MD	Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Stefan Bittner	Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
H. Bockholt	No disclosure on file
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
John DeLuca, PhD, ABPP	Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Urvi G. Desai, MD, FAAN	Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
David T. Jones, MD	Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
David A. Marks, MD	Dr. Marks has nothing to disclose.
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Nimish A. Mohile, MD, FAAN	The institution of Dr. Mohile has received research support from Novocure.
Heather Moss, MD, PhD, FAAN	Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Jennifer L. Reardon	Jennifer L. Reardon has received personal compensation for serving as an employee of Bristol Myers Squibb.
Bernd F. Remler, MD	No disclosure on file
Jennifer N. Serventi, PA	Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Vijay Sharma	No disclosure on file
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Jinny O. Tavee, MD	Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
Rebecca Traub, MD, FAAN	Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext. The institution of Dr. Traub has received research support from Immunovant. The institution of Dr. Traub has received research support from Takeda. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a consultant with Department of Justice.
Crystal T. Wong, MD	No disclosure on file
Charles Wira	Charles Wira has nothing to disclose.
Jay-Jiguang Zhu, MD, PhD, FAAN	The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc.
Jeffrey Waugh, MD, PhD, FAAN	Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Daniel T. Laskowitz, MD	No disclosure on file
Scott R. Plotkin, MD, PhD, FAAN	Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Michiko K. Bruno, MD, FAAN	The institution of Dr. Bruno has received research support from Michael J. Fox Foundation . The institution of Dr. Bruno has received research support from PIKO. The institution of Dr. Bruno has received research support from CurePSP. The institution of Dr. Bruno has received research support from Parkinson's Foundation .
Thomas Wychowski, MD	The institution of Dr. Wychowski has received research support from UCB.
Rajeev Motiwala, MD, FAAN	Dr. Motiwala has nothing to disclose.
Paul B. Pritchard III, MD	No disclosure on file
Cary L. Twyman, MD, FAAN	No disclosure on file
Patricia Greenstein, MD	Dr. Greenstein has nothing to disclose.
Michael Weller, MD	Dr. Weller has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurosense. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medac. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Philogen. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Weller has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure. The institution of Dr. Weller has received research support from Versameb.
David C. Spencer, MD, FAAN	Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuiticals. Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Spencer has received research support from NIH. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative ��ɫ�� Concepts.
Liesly Lee, MD	Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Pratap R. Chand, MD, FRCP, FAAN	Dr. Chand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Neuroscience.
Guojun Zhao, MD	No disclosure on file
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Teri Schreiner, MD, MPH, FAAN	The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Christopher R. Newey, DO	Dr. Newey has nothing to disclose.
Nada El Husseini, MD, FAAN	Dr. El Husseini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. El Husseini has received research support from the DISCOVERY trial funded by the National Institute of Neurological Disorders and Stroke (NINDS)and the National Institute on Aging (NIA) (U19NS115388).- subcontract from MGH. The institution of Dr. El Husseini has received research support from American Heart Association. The institution of Dr. El Husseini has received research support from PCORI.
Damien Ricard, MD	No disclosure on file
Mario R. Cornejo Olivas, MD	Dr. Cornejo Olivas has received research support from UNIVERSIDAD CIENTIFICA DEL SUR. The institution of Dr. Cornejo Olivas has received research support from CHDI. The institution of Dr. Cornejo Olivas has received research support from NIH. The institution of Dr. Cornejo Olivas has received research support from GP2/ASAP/MJFF. Dr. Cornejo Olivas has a non-compensated relationship as a Secretary elect with MDS-PAS that is relevant to AAN interests or activities.
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Oluwadamilola O. Ojo, MD	Dr. Ojo has nothing to disclose.
Katherine L. Possin, PhD	Dr. Possin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ClearView Healthcare Partners. The institution of Dr. Possin has received research support from Quest Diagnostics. The institution of Dr. Possin has received research support from NIH. The institution of Dr. Possin has received research support from The Global Brain Health Institute. The institution of Dr. Possin has received research support from The Rainwater Foundation.
Elizabeth A. Coon, MD, FAAN	Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Paulus S. Rommer	Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Kate T. Brizzi, MD	Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Fern Health. Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon.
Matthew Brier, MD, PhD	Dr. Brier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Brier has received research support from NIH.
Shivani Ghoshal, MD	Dr. Ghoshal has nothing to disclose.
Sara Hardy, MD	Dr. Hardy has received research support from the American Cancer Society.
Harald Hegen, MD	Dr. Hegen has nothing to disclose.
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Vanessa Merker	The institution of Vanessa Merker has received research support from Children's Tumor Foundation . The institution of Vanessa Merker has received research support from NF Northeast. The institution of Vanessa Merker has received research support from Patient Centered Outcomes Research Institute. The institution of Vanessa Merker has received research support from U.S. Department of Defense . The institution of Vanessa Merker has received research support from Neurofibromatosis Therapeutic Accleration Project. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a Science Writer with Neurofibromatosis Network.
Caterina Motta	Caterina Motta has nothing to disclose.
Chahin Pachai	Chahin Pachai has received personal compensation for serving as an employee of Bristol Myers Squibb. Chahin Pachai has stock in Bristol-Myers Squibb.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Carrie Sammarco	Carrie Sammarco has nothing to disclose.
Patrice Whitehead	No disclosure on file
Tarso Adoni, MD, PhD, FAAN	Dr. Adoni has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Anjail Sharrief, MD	The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to AAN interests or activities.
Swapna L. Putta, MD	No disclosure on file
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Roberta J. Seidman, MD	Dr. Seidman has nothing to disclose.
Claude Steriade, MD	The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals. Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Speakers Bureau with SK Life Sciences. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as a Speakers Bureau with Neurelis. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Xenon Pharmaceuticals.
Agnes Kowalska, MD	Dr. Kowalska has nothing to disclose.
Barbara Willekens, MD, PhD, FAAN	The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall . The institution of Dr. Willekens has received research support from Roche. The institution of Dr. Willekens has received research support from Janssen. Dr. Willekens has a non-compensated relationship as a Co-chair scientific panel of neuroimmunology with European Academy of Neurology that is relevant to AAN interests or activities.
Jacqueline Urtecho, MD	Dr. Urtecho has nothing to disclose.
Said R. Beydoun, MD, FAAN	Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Beydoun has received research support from Abcuro. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Regeneron. The institution of Dr. Beydoun has received research support from RemeGen. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Novartis.
Keith Van Haren, MD	Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Justin T. Jordan, MD, MPH, FAAN	Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care.
Kiran P. Maski, MD	An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
Melinda Magyari, MD	Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Abdulaziz Ashkanani, BMBCH, FRCPC, FAAN	No disclosure on file
Temitope A. Lawal, MD	Dr. Lawal has nothing to disclose.
Karan S. Dixit, MD	Dr. Dixit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Pichet Termsarasab, MD	No disclosure on file
Ina Ly, MD	An immediate family member of Dr. Ly has received personal compensation for serving as an employee of Enanta Pharmaceuticals. Dr. Ly has received research support from Department of Defense. An immediate family member of Dr. Ly has received intellectual property interests from a discovery or technology relating to health care.
Nandakumar Narayanan, MD, PhD	Dr. Narayanan has nothing to disclose.
Elise P. Kayson, RN	Elise Paulin Kayson, RN has nothing to disclose.
Federico Casale	No disclosure on file
Kym Boycott	No disclosure on file
Matthis Synofzik	Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD.
Natasa Dragasevic	No disclosure on file
Nobuaki Yoshikura, MD, PhD	Dr. Yoshikura has nothing to disclose.
Scott Brittain	No disclosure on file
Shravan Sivakumar, MBBS	Dr. Sivakumar has nothing to disclose.
Umberto Manera, MD	Dr. Manera has nothing to disclose.
Mark T. Brown, MD	Dr. Brown has received personal compensation for serving as an employee of Pfizer Inc. Dr. Brown has received stock or an ownership interest from Pfizer Inc.
Ricky Lee, MD	No disclosure on file
Wenyu Sun, MD	No disclosure on file
Christopher Ross, MD, PhD	Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniqure. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitoconix. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuBase. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Huntington Study Group. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitoconix. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuBase. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mintz. Christopher Ross, MD, PhD has received intellectual property interests from a discovery or technology relating to health care. Christopher Ross, MD, PhD has a non-compensated relationship as a consultant with Huntington Study Group that is relevant to AAN interests or activities.
David R. Benavides, MD, PhD, FAAN	The institution of Dr. Benavides has received research support from NIH/NINDS. The institution of Dr. Benavides has received research support from F. Hoffman La Roche Ltd.
Vikram Prakash, MD	Dr. Prakash has nothing to disclose.
Sherri A. Braksick, MD, FAAN	Dr. Braksick has nothing to disclose.
Regina Krel, MD	No disclosure on file
Eric Thouvenot, MD, PhD	Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Bassam Malo, MD	No disclosure on file
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Hristelina S. Ilieva, MD	The institution of Dr. Ilieva has received research support from ALSA. Dr. Ilieva has received personal compensation in the range of $0-$499 for serving as a reviewer with DOD.
Ilana B. Katz Sand, MD	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with ��ɫ��.
Suzanne E. Schindler, MD, PhD	Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Schindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Schindler has received research support from National Institute on Aging. Dr. Schindler has received personal compensation in the range of $0-$499 for serving as a Member of the Biospecimen Review Committee with National Centralized Repository for Alzheimer Disease. Dr. Schindler has a non-compensated relationship as a Board Member with Greater Missouri Alzheimer's Association that is relevant to AAN interests or activities.
Sandeep S. Rana, MD, FAAN	Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Marcos Aleandre Carneiro	No disclosure on file
Jamie Greenfield	No disclosure on file
Christian Lachner	Christian Lachner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView. Christian Lachner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group Services.
David K. Li, MD	Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
Juan Llibre	No disclosure on file
Jeffrey D. Long	Jeffrey Long has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Triplet. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vacinnex. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave. Jeffrey Long has received personal compensation in the range of $0-$499 for serving as a Consultant for PTC. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Jeffrey Long has received research support from NIH DSMB.
Michael W. Ruff, MD	Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Radmetrix. Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Ruff has received intellectual property interests from a discovery or technology relating to health care.
Rabia Malik, MD	Dr. Malik has nothing to disclose.
Federico Silva	Federico Silva has nothing to disclose.
Robert I. Thompson-Stone, MD, FAAN	Dr. Thompson-Stone has received personal compensation in the range of $500-$4,999 for serving as a Krabbe Disease expert with Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Dr. Thompson-Stone has a non-compensated relationship as a Editorial Board Member with Neurology: ��ɫ�� Journal that is relevant to AAN interests or activities.
Victor W. Sung, MD	Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure.
Manon Thibault, MD	No disclosure on file
Felix M. Veloso, MD, FAAN	No disclosure on file
Shashishekha J. Lamdhade, MD	No disclosure on file
Fadi K. Abou-Mrad, MD, PhD, FAAN	Dr. Abou-Mrad has nothing to disclose.
Joshua Bonkowsky, MD, PhD	Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bonkowsky has stock in Orchard. The institution of Dr. Bonkowsky has received research support from NIH. The institution of Dr. Bonkowsky has received research support from ELA. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
Rejean M. Guerriero, MD	Dr. Guerriero has nothing to disclose.
Andres Fernandez, MD	Dr. Fernandez has nothing to disclose.
Carolyn J. Bevan, MD	Dr. Bevan has received intellectual property interests from a discovery or technology relating to health care.
Makoto Ishii, MD, PhD	Dr. Ishii has stock in Regeneron Pharmaceuticals. The institution of Dr. Ishii has received research support from NIH. The institution of Dr. Ishii has received research support from BrightFocus Foundation. The institution of Dr. Ishii has received research support from Alzheimer's Association. Dr. Ishii has received personal compensation in the range of $0-$499 for serving as a Author/Contributor with Relias Media.
Zhi-Jian Chen, MD	Dr. Chen has nothing to disclose.
Simona V. Proteasa, MD	Dr. Proteasa has nothing to disclose.
Ulrich Fulda, MD	No disclosure on file
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Bardia Nourbakhsh, MD	Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from National MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH. The institution of Dr. Nourbakhsh has received research support from Axsome Therapeutics. The institution of Dr. Nourbakhsh has received research support from TG Therapeutics .
Brett A. McCray, MD	The institution of Dr. McCray has received research support from NIH. The institution of Dr. McCray has received research support from Johns Hopkins Merkin Peripheral Neuropathy and Nerve Regeneration Center. The institution of Dr. McCray has received research support from Muscular Dystrophy Association.
Amanda Tinsley, MD	No disclosure on file
Ivana Vodopivec, MD	Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche.
Padmaja Sudhakar, MD	Dr. Sudhakar has nothing to disclose.
Marissa Kellogg, MD, MPH, FAAN	The institution of Dr. Kellogg has received research support from VA & DoD.
Karen D. Orjuela, MD, FAAN	The institution of Dr. Orjuela has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Orjuela has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Orjuela has received research support from Abbott. The institution of Dr. Orjuela has received research support from NIH . The institution of Dr. Orjuela has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Orjuela has received research support from American Heart Association and Bristol Myers Squibb Foundation.
Emily L. McGinnis, MD	No disclosure on file
Yana Krutoshinskaya, MD	Dr. Krutoshinskaya has nothing to disclose.
Danielle B. Pier, MD	No disclosure on file
Nicholas L. Zalewski, MD	Dr. Zalewski has nothing to disclose.
Aparna Sarma, DO	No disclosure on file
Manav Vyas, MD	The institution of Dr. Vyas has received research support from Heart and Stroke Foundation of Canada . The institution of Dr. Vyas has received research support from Canadian Institutes of Health Research . Dr. Vyas has received research support from Heart and Stroke Foundation of Canada .
Yuishin Izumi, MD, PhD	No disclosure on file
Welton O'Neal, Jr., PharmD	No disclosure on file
Tobias Ruck	No disclosure on file
Raymond Hupperts	No disclosure on file
Josef M. Gutman, MD	Dr. Gutman has nothing to disclose.
Nan Jiang, MD	Dr. Jiang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for • Amylyx . Dr. Jiang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen .
Jessica E. Rexach, MD, PhD	Dr. Rexach has nothing to disclose.
Hugo Botha, MD	Dr. Botha has received research support from NIH. An immediate family member of Dr. Botha has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Rachel Beekman, MD	Dr. Beekman has nothing to disclose.
Homa Ebrahimi, MD	No disclosure on file
James Lanska	No disclosure on file
Kathleen Sullivan	No disclosure on file
Agessandro Abrahao, Jr., MD	Dr. Abrahao has nothing to disclose.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Angela Kokkinis	Angela Kokkinis has nothing to disclose.
Colin Dayan	Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Provention Bio. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli-Lilly. Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Provention Bio. Colin Dayan has received intellectual property interests from a discovery or technology relating to health care.
Edoardo G. Spinelli, MD	Dr. Spinelli has nothing to disclose.
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care.
Guojun Bu	No disclosure on file
Jalesh Panicker	Jalesh Panicker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Coloplast . Jalesh Panicker has received publishing royalties from a publication relating to health care.
Jia Cheng	No disclosure on file
Kiyonori Kai	No disclosure on file
Leorah A. Freeman, MD, PhD	Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hoffman La-Roche. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono/ Merck. The institution of Dr. Freeman has received research support from Genentech. The institution of Dr. Freeman has received research support from PCORI. The institution of Dr. Freeman has received research support from EMD Serono. The institution of Dr. Freeman has received research support from Sanofi. The institution of Dr. Freeman has received research support from MSAA. The institution of Dr. Freeman has received research support from National Multiple Sclerosis Society.
Michael Auer	Michael Auer has nothing to disclose.
Naomichi Matsumoto	No disclosure on file
Naotoshi Yamamura	No disclosure on file
Paolina Salamone	No disclosure on file
Paul Mehta	Paul Mehta has nothing to disclose.
Paulo Bertolucci	No disclosure on file
Rosalind Mandelbaum	No disclosure on file
Yuka Koike	No disclosure on file
Scott Grossman, MD	Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Dong Zhou	Dong Zhou has nothing to disclose.
Catherine E. Otten, MD	The institution of Dr. Otten has received research support from CDC.
Sameer Sharma, MD, MBBS	Dr. Sharma has nothing to disclose.
Hsiangkuo Yuan, MD, PhD	An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Salvia. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovous. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regional Anesthesia and Pain Medicine. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Headache and Pain Reports. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. The institution of Dr. Yuan has received research support from NIH. The institution of Dr. Yuan has received research support from American Headache Society. The institution of Dr. Yuan has received research support from Pfizer. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Invited speaker with Chinese Stroke Association.
Kathryn A. Davis, MD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals/Jazz Pharmaceuticals. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Davis has received research support from Eisai. The institution of Dr. Davis has received research support from Liminal. Dr. Davis has received publishing royalties from a publication relating to health care.
DeWitt D. Pyburn, MD	Dr. Pyburn has nothing to disclose.
Seyed A. Fatemi, MD, MBA	Dr. Fatemi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for RCO law. The institution of Dr. Fatemi has received research support from Minoryx. The institution of Dr. Fatemi has received research support from Viking Therapeutics. The institution of Dr. Fatemi has received research support from Swanbio Therapeutics . The institution of Dr. Fatemi has received research support from Autobahn Therapeutics. The institution of Dr. Fatemi has received research support from Nuvelution. The institution of Dr. Fatemi has received research support from NIH. The institution of Dr. Fatemi has received research support from A Cure for Ellie Foundation. The institution of Dr. Fatemi has received research support from Brian's Hope Foundation . Dr. Fatemi has received intellectual property interests from a discovery or technology relating to health care. Dr. Fatemi has a non-compensated relationship as a Director (Board member) with ALDConnect that is relevant to AAN interests or activities.
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
James N. Brenton, MD, FAAN	Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Michelle Kaku, MD	Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
Peter V. Rasmussen, MD	Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Surabhi Ranjan, MD	Dr. Ranjan has nothing to disclose.
Clinton G. Lauritsen, MD	Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan.
NgocHanh H. Vu, MD	Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health.
Antonio Canosa	Antonio Canosa has nothing to disclose.
Shivika Chandra, MD, FAAN	The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in ��ɫ�� Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Orwa Aboud, MD, PhD	Dr. Aboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aboud LLC.
Alyssa Nylander, MD, PhD	Dr. Nylander has nothing to disclose.
Christian Cordano, MD, PhD	Dr. Cordano has nothing to disclose.
Eric Lipp	No disclosure on file
Hadi M. Mohammad Khanli, MD	Dr. Mohammad Khanli has nothing to disclose.
Eyal Muscal	Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer.
Tyler E. Smith, MD	Dr. Smith has received research support from National Multiple Sclerosis Society. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a neurobytes author with ��ɫ��.
Mariana Suarez	No disclosure on file
Mithilesh Siddu, MD	Dr. Siddu has nothing to disclose.
Cynthia X. Wang, MD	Dr. Wang has nothing to disclose.
Yin A. Liu, MD, FAAN	Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Courtney E. McIlduff, MD	The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care.
Lauren Jackson, MD	Dr. Jackson has nothing to disclose.
James Overell, MD, MBBS	Dr. Overell has received personal compensation for serving as an employee of Roche. Dr. Overell has stock in Roche.
Lisa T. Emrick, MD	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Franziska Di Pauli	Franziska Di Pauli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for horizon. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Franziska Di Pauli has received research support from Roche.
Abdulrahman O. Al Harbi, MD	Dr. Al Harbi has nothing to disclose.
Ethan G. Brown, MD	Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Matthias Kant	Matthias Kant has nothing to disclose.
Binod Wagle, MD, FAAN	Dr. Wagle has nothing to disclose.
Eyal Y. Kimchi, MD, PhD	The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH.
Zsolt Illes, MD	No disclosure on file
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Ilana L. Kahn, MD	Dr. Kahn has nothing to disclose.
Simy K. Parikh, MD	Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parikh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Author with Medlink. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Touch Independent Medical ��ɫ�� (touchIME) . Dr. Parikh has a non-compensated relationship as a Medical Advisory Board Member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
Marisa P. McGinley, DO	Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono.
Jennifer M. Martinez-Thompson, MD, FAAN	Dr. Martinez-Thompson has nothing to disclose.
Andrea C. Wasilewski, MD	Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals . Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals .
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Nidhiben A. Anadani, MD	Dr. Anadani has nothing to disclose.
Ifrah Zawar, MD	The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . The institution of Dr. Zawar has received research support from NIH. The institution of Dr. Zawar has received research support from University of Virginia.
Elina Zakin, MD, FAAN	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Matthew R. Burns, MD, PhD	The institution of Dr. Burns has received research support from NIH. The institution of Dr. Burns has received research support from Mcknight Brain Institute.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Jonathan Urrego	Jonathan Urrego has nothing to disclose.
Carol Swetlik, MD	An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Gabriel Bsteh, MD	Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Fawad Yousuf, MBBS	Dr. Yousuf has nothing to disclose.
Catherine Ashton, MBBS	Dr. Ashton has nothing to disclose.
Silvia Basaia	Silvia Basaia has nothing to disclose.
Chiew Hong	No disclosure on file
Alexandra B. Kornbluh, MD	Dr. Kornbluh has nothing to disclose.
Theodore Larson	Theodore Larson has nothing to disclose.
Johannes Lorscheider	The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Johannes Lorscheider has received research support from Innosuisse - Swiss Innvation Ageny. The institution of Johannes Lorscheider has received research support from MSBase Foundation. The institution of Johannes Lorscheider has received research support from Novartis.
Prasad Malladi	No disclosure on file
Monica Margoni	Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Daniel Moreno-Zambrano, MD	Dr. Moreno-Zambrano has nothing to disclose.
Adam Staffaroni	Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aviado Bio. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CervoMed. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prevail Therepeutics/Eli Lilly. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Adam Staffaroni has received research support from NIH. The institution of Adam Staffaroni has received research support from Bluefield Project To Cure FTD. The institution of Adam Staffaroni has received research support from AFTD/ALSA. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Scientific Advisory Board member with AADF.
Jeffrey B. Ratliff, MD, FAAN	Dr. Ratliff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for the journal Neurology. The institution of Dr. Ratliff has received research support from Scion NeuroStim, LLC.
Fanny M. Elahi, MD, PhD	Dr. Elahi has nothing to disclose.
Andreia Mendonca	No disclosure on file
Eufrosina I. Young, MD	The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Kathleen B. Mullin, MD	Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Vorso. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Steven R. Dunham, Jr., MD	Dr. Dunham has nothing to disclose.
Sheila C. Suarez, MD	Dr. Suarez has nothing to disclose.
Antje Bischof, MD	Dr. Bischof has nothing to disclose.
Michael Gelfand, MD, PhD	Dr. Gelfand has received personal compensation in the range of $0-$499 for serving as a Consultant for Aquestive. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. The institution of Dr. Gelfand has received research support from Aquestive. The institution of Dr. Gelfand has received research support from Xenon. The institution of Dr. Gelfand has received research support from Cerevel. The institution of Dr. Gelfand has received research support from UNEEG. The institution of Dr. Gelfand has received research support from Livanova. The institution of Dr. Gelfand has received research support from UCB. The institution of Dr. Gelfand has received research support from SK Pharma. The institution of Dr. Gelfand has received research support from Otsuka.
Lauren Gluck, MD	Dr. Gluck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeautics. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Rare Disease. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Leila Darki, MD, FAAN	Dr. Darki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partner. Dr. Darki has received personal compensation in the range of $0-$499 for serving as a Consultant for Guide point Global. Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Global Access Meetings. Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx . Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx.
Carla D. Zingariello, DO	The institution of Dr. Zingariello has received research support from ML Bio. The institution of Dr. Zingariello has received research support from Edgewise Therapeutics.
Megan E. Esch, MD	The institution of Dr. Esch has received research support from PCORI.
Robert J. Marquardt, DO	Dr. Marquardt has nothing to disclose.
Sarah Horn, MD	Dr. Horn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Horn has received research support from Alzheimer's Association.
Qiang J. Zhang, MD	The institution of Dr. Zhang has received research support from NIH/NIA.
Madihah A. Hepburn, MD	Dr. Hepburn has nothing to disclose.
Ahmad Al-Awwad, MD	Dr. Al-Awwad has nothing to disclose.
Nancy Song, MD	Dr. Song has nothing to disclose.
Xiaoyan Li, MD	Dr. Li has nothing to disclose.
Coral M. Stredny, MD	Dr. Stredny has stock in Proctor and Gamble. The institution of Dr. Stredny has received research support from Pediatric Epilepsy Research Foundation.
Edward J. Wild, MBBS, PhD, MRCP	Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Wild has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Skyhawk Therapeutics. Dr. Wild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis Pharmacauticals. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman La Roche. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vico Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. The institution of Dr. Wild has received research support from CHDI Foundation (non-profit).
Karina Milla-Neyra	No disclosure on file
Negin Badihian, MD	Dr. Badihian has nothing to disclose.
Maryenela Z. Illanes-Manrique, MD, Atlantic Fellow	The institution of Dr. Illanes-Manrique has received research support from GLOBAL BRAIN HEALTH INSTITUTE.
John Boscardin	No disclosure on file
Harry Sutherland, MD	Dr. Sutherland has received publishing royalties from a publication relating to health care.
Jamie Wong, PhD	Dr. Wong has nothing to disclose.
Jonah Chan, PhD	Jonah Chan, PhD has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Contineum Therapeutics. Jonah Chan, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SFN. Jonah Chan, PhD has stock in Contineum Therapeutics. The institution of Jonah Chan, PhD has received research support from Mead Johnson. Jonah Chan, PhD has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH/NINDS.
Reydmar Lopez	Reydmar Lopez has nothing to disclose.
Guillermo Gonzalez-Manrique	Guillermo Gonzalez-Manrique has nothing to disclose.
Cindy Beltran	No disclosure on file
Lyda Osorio	Lyda Osorio has nothing to disclose.
Beatriz Parra	Beatriz Parra has nothing to disclose.
Alit Bhatt	Alit Bhatt has nothing to disclose.
Andrew Christiana, MD	Dr. Christiana has nothing to disclose.
Jaime Raymond	Jaime Raymond has nothing to disclose.
D Kevin Horton	No disclosure on file
Sarah Wright, PhD, MBChB	Dr. Wright has nothing to disclose.
James K. Sheffield, MD	Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Tina Liu, MD	Dr. Liu has nothing to disclose.
James F. Rini, MD	Dr. Rini has a non-compensated relationship as a Member on Advisory Board with Lilly that is relevant to AAN interests or activities. Dr. Rini has a non-compensated relationship as a Member on Advisory Board with CND Lifesciences that is relevant to AAN interests or activities.
Michael V. Robers, MD	Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation.
Walter Maier-Janson, MD	Dr. Maier-Janson has nothing to disclose.
Kevin A. Mazurek, PhD	Dr. Mazurek has received personal compensation for serving as an employee of Delos Living / Well Living Lab. Dr. Mazurek has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Mazurek has a non-compensated relationship as a Editor with AAN Resident and Fellows Section that is relevant to AAN interests or activities.
Akio Kimura, MD	Dr. Kimura has nothing to disclose.
Ethan Murphy	No disclosure on file
Yesenia Enriquez-Gonzalez, MD	Dr. Enriquez-Gonzalez has nothing to disclose.
Tarini Goyal	Dr. Goyal has nothing to disclose.
Arunmozhimaran Elavarasi, MD	Dr. Elavarasi has stock in Pfizer. Dr. Elavarasi has stock in PGHL. The institution of Dr. Elavarasi has received research support from All India Institute of Medical Sciences, New Delhi. The institution of Dr. Elavarasi has received research support from Indian Council for Medical Research.
Mohammed Qureshi, MD	Dr. Qureshi has nothing to disclose.
Larry Adams	No disclosure on file
Michael L. Cuccaro	No disclosure on file
Yi-Chen Lai	No disclosure on file
Denise Diniz Carneiro	Denise Diniz Carneiro has nothing to disclose.
Marjorie Miraldo	No disclosure on file
Maria Naffah-Mazzacoratti	No disclosure on file
Tobias Sejbaek, MD, PhD	Prof. Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, NeuroXpharm, Novartis, Roche, Sandoz and Sanofi. The institution of Prof. Sejbaek has received research support from Merck, Novartis, Roche and Sanofi.
Martha Mulvey	No disclosure on file
Sarah Woidill	Sarah Woidill has nothing to disclose.
Francesco Gavazzi, MD, MD, PhD	The institution of Dr. Gavazzi has received research support from NIH. The institution of Dr. Gavazzi has received research support from NIH, NINDS. The institution of Dr. Gavazzi has received research support from IONIS Pharmaceuticals.
Justine Shults	No disclosure on file
Laura A. Adang, MD	Dr. Adang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orchard Therapeutics.
Amra Sakusic, MD	Dr. Sakusic has nothing to disclose.
Jonathan Santoro, MD	Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Payal P. Soni, MD	Dr. Soni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Brandon Giglio, MD	Dr. Giglio has nothing to disclose.
Camille S. Corre, MD	Dr. Corre has nothing to disclose.
Shivani Naik, MD	Dr. Naik has nothing to disclose.
Duriel I. Hardy, MD	Dr. Hardy has nothing to disclose.
Katalina McInerney	Katalina McInerney has nothing to disclose.
Justin Hoskin, MD	Dr. Hoskin has nothing to disclose.
Barbara Kornek, MD	Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS Celgene. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson&Johnson. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Kornek has received research support from Novartis.
Joy E. Burke, MD	No disclosure on file
Jorge Angarita, MD	Dr. Angarita has nothing to disclose.
Kristen Fisher, DO	Dr. Fisher has nothing to disclose.
Shannon M. Beres, MD	Dr. Beres has nothing to disclose.
Scott I. Otallah, MD	Dr. Otallah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck.
Erin C. Conrad, MD	Dr. Conrad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. Dr. Conrad has stock in Humana. Dr. Conrad has stock in Lilly Eli. Dr. Conrad has stock in Medtronic. Dr. Conrad has stock in Merck. Dr. Conrad has stock in Nevro. Dr. Conrad has stock in Sanofi. Dr. Conrad has stock in United Health Group.
Eric J. Mallack, MD	Dr. Mallack has received research support from NINDS.
Hannah Kirsch, MD	An immediate family member of Dr. Kirsch has stock in Genentech.
Lindsay Ross, MD	Dr. Ross has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapuetics. Dr. Ross has received publishing royalties from a publication relating to health care.
Monica K. Johnson, MD	Dr. Johnson has a non-compensated relationship as a Advisory Board Member with LiveOn OPO that is relevant to AAN interests or activities.
Tammy L. Smith, MD, PhD	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Rory Abrams, MD	Dr. Abrams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas Pharmaceutical.
Amanda Rogers, MD	An immediate family member of Dr. Rogers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medpace.
David Pellerin, MD	Dr. Pellerin has nothing to disclose.
Diana Angelika Olszewska, MD, PhD	Dr. Olszewska has nothing to disclose.
Lauryn Hemminger	Dr. Hemminger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Ahmad Mahadeen, MD	Dr. Mahadeen has nothing to disclose.
Ryan Kammeyer, MD	The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center.
Christian Amlang, MD	Dr. Amlang has nothing to disclose.
Christy Smith	No disclosure on file
Sarah Harris	Sarah Harris has received personal compensation for serving as an employee of BMS. Sarah Harris has stock in BMS.
Andrew Dhawan, MD	Dr. Dhawan has nothing to disclose.
Erin Barnes, MD	An immediate family member of Dr. Barnes has received personal compensation for serving as an employee of Go2For Lung Cancer. The institution of Dr. Barnes has received research support from NIH.
Dan Tong Jia, MD	Dr. Jia has nothing to disclose.
Rosario Vasta, MD	Dr. Vasta has nothing to disclose.
Giuseppina Pilloni, PhD	Dr. Pilloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceragem.
Irina Agarkova	No disclosure on file
Melissa Beiner	Melissa Beiner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Melissa Beiner has stock in Biohaven Pharmaceuticals.
Julie Benavides	Julie Benavides has nothing to disclose.
Mashina Chomba, MBChB	Dr. Chomba has nothing to disclose.
Brenda Deliz Roldan	No disclosure on file
Siena Duarte, MD, MAS	Dr. Duarte has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Duarte has received personal compensation for serving as an employee of University of California, San Francisco.
David Dunigan	No disclosure on file
Piotr Kamieniak	No disclosure on file
Rajesh Kumar Singh	Rajesh Kumar Singh has nothing to disclose.
Caroline Streicher	Caroline Streicher has received personal compensation for serving as an employee of Axsome Therapeutics. Caroline Streicher has stock in Axsome Therapeutics.
Tom Petro	No disclosure on file
James Van Etten	No disclosure on file
Elizabeth Herries	No disclosure on file
Martha Moyano	Martha Moyano has nothing to disclose.
Jaime Quintero	No disclosure on file
Pashtun-Poh Shahim, MD, PhD	Pashtun-Poh Shahim has nothing to disclose.
Ragha Sakuru, MD	Dr. Sakuru has nothing to disclose.
Dorothy Schafer	No disclosure on file
Mohammed K. Badi, MD	Dr. Badi has nothing to disclose.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Jessica White, MD	Dr. White has nothing to disclose.
Rumyar V. Ardakani, MD	Dr. Ardakani has nothing to disclose.
Kelly A. Boylan, MD	Dr. Boylan has nothing to disclose.
Allen H H. Heller, MD, MPH	Dr. Heller has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Epalex Corporation. Dr. Heller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aquestive Therapeutics Inc.. Dr. Heller has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celanese Corporation. Dr. Heller has stock in Epalex Corporation.
Fritz Leutmezer	Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. The institution of Fritz Leutmezer has received research support from Biogen, Merck, Novartis, Roche.
Jon Riolo, PhD	Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Berthold Pemp, MD	Dr. Pemp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Pemp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Pemp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GenSight. The institution of Dr. Pemp has received research support from Chiesi.
Mark Girgis, DO	Dr. Girgis has nothing to disclose.
Robert Fountaine	Robert Fountaine has received personal compensation for serving as an employee of Pfizer, Inc.. Robert Fountaine has or had stock in Pfizer, Inc.Robert Fountaine has or had stock in Viatris, Inc.
Ryan Halter	No disclosure on file
Stephen Apple	Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Sahil Naik, MD	Dr. Naik has nothing to disclose.
Sarah Verga	Miss Verga has nothing to disclose.
Sean Levy	No disclosure on file
Jenny P. Garzon, MD	Dr. Garzon has nothing to disclose.
Alexander Sandweiss, MD, PhD	Dr. Sandweiss has nothing to disclose.
Christopher William	Christopher William has nothing to disclose.
Anthony J. Griswold, PhD	Dr. Griswold has received research support from National Institutes of Health.
Farid Rajabli, PhD	Farid Rajabli has nothing to disclose.
Mar Guasp, MD	Dr. Guasp has nothing to disclose.
Katherine Claros	Katherine Claros has nothing to disclose.
Viviana Martinez	Viviana Martinez has nothing to disclose.
Sung-Min Cho	No disclosure on file
Rachel Galioto	Rachel Galioto has nothing to disclose.
Gina Norato	Gina Norato has nothing to disclose.
Elison Sarapura-Castro, MD	Dr. Sarapura-Castro has nothing to disclose.
Jennifer H. Yang, MD	Dr. Yang has received research support from Pediatric Epilepsy Research Foundation. Dr. Yang has received research support from NIH.
Maurizio Grassano, MD	Dr. Grassano has received research support from American Brain Foundation, ALS Association and ��ɫ��.
Nathalia Figueiredo, MD	Dr. Figueiredo has nothing to disclose.
Christina Law, MD, MEd	Dr. Law has nothing to disclose.
Tobias Zrzavy	Tobias Zrzavy has nothing to disclose.
Patrick Altmann	The institution of Mr. Altmann has received research support from Quanterix. The institution of Mr. Altmann has received research support from Biogen, Merck, Roche, Sanofi, Teva,. Mr. Altmann has received intellectual property interests from a discovery or technology relating to health care.
Mahmoud Dibas, MD	Mr. Dibas has nothing to disclose.
Alexander Maslov, MD	Dr. Maslov has nothing to disclose.
Jennifer Zitser-Koren, MD	Dr. Zitser-Koren has nothing to disclose.
Ghazal Ahmad, MD	Dr. Ahmad has nothing to disclose.
Amy Brown, MD	Dr. Brown has nothing to disclose.
Arkadiusz Weglewski	Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Weglewski has received publishing royalties from a publication relating to health care. Dr. Weglewski has received publishing royalties from a publication relating to health care.
Morten Leif Munding Stilund	Morten Leif Munding Stilund has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicinske Tidsskrifter.
Melissa A. Wright, MD	Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Saima Kayani, MD	Dr. Kayani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogene. The institution of Dr. Kayani has received research support from Neurogene. The institution of Dr. Kayani has received research support from NIH.
Victor Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Melody T. Asukile, MBBS	Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. The institution of Dr. Asukile has received research support from Leverhulme Trust. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Eileen Harrigan, MD	Dr. Harrigan has nothing to disclose.
Sandro Almeida	No disclosure on file
Sadia Waheed, MBBS	Dr. Waheed has nothing to disclose.
Baljinder Singh, MD	Dr. Singh has nothing to disclose.
Ahya S. Ali, MD	Dr. Ali has nothing to disclose.
Jorge E. Patino Murillas, MD	Dr. Patino Murillas has nothing to disclose.
Zachary Lodato, DO	Dr. Lodato has nothing to disclose.
Frederike Cosima Oertel, MD	The institution of Dr. Oertel has received research support from AAN. The institution of Dr. Oertel has received research support from Hertie Foundation. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ECTRIMS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with NMSS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ACTRIMS.
Frighton B. Mutete, MBChB	Dr. Mutete has nothing to disclose.
Eduardo Castro-Neto	No disclosure on file
Kenjiro Kunieda	Kenjiro Kunieda has nothing to disclose.
Moon Han, PhD	Dr. Han has nothing to disclose.
Damiano Mistri, MSC	Mr. Mistri has nothing to disclose.
Kazuhiro Higashida	Kazuhiro Higashida has nothing to disclose.
Evangelos Pavlos Myserlis, MD	The institution of Dr. Myserlis has received research support from ��ɫ��. Dr. Myserlis has received personal compensation in the range of $500-$4,999 for serving as a AAN Resident Scholarship to the Annual Meeting Recipient with ��ɫ��.
Eu Jene Choi, MD, PhD(c)	Dr. Choi has nothing to disclose.
Anza Zahid, MD, MBBS	Dr. Zahid has nothing to disclose.
Rachel Henson	No disclosure on file
Markus Ponleitner	Markus Ponleitner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics, Inc.. Markus Ponleitner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amicus Therapeutics Inc.. Markus Ponleitner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Markus Ponleitner has received research support from European Academy of Neurology.
Shivany Condor Montes	No disclosure on file
David Acero-Garces, MD	Dr. Acero-Garces has nothing to disclose.
Daniel Bennett	No disclosure on file
Michael Terranova	Michael Terranova has nothing to disclose.
Daven Crossland	No disclosure on file
Daniela Zuluaga Lotero	No disclosure on file
Theresa Driscoll	No disclosure on file
Tobias Monschein	No disclosure on file
Jennifer Da	No disclosure on file
Evelyn Lazar, MD	Dr. Lazar has nothing to disclose.
Gudrun Zulehner	No disclosure on file
Matt Danzi	Matt Danzi has nothing to disclose.
Bavica Gummadi, DO	Dr. Gummadi has nothing to disclose.
Jarrett Leech, MD	Dr. Leech has nothing to disclose.
Kyle R. Marden, MD	Dr. Marden has nothing to disclose.
Jose Enrique Vargas Manotas, MD, MSc	Dr. Vargas Manotas has nothing to disclose.
Krista L. Eschbach, MD	The institution of Dr. Eschbach has received research support from Neurocrine Biosciences. The institution of Dr. Eschbach has received research support from UCB Biopharma. The institution of Dr. Eschbach has received research support from Pediatric Epilepsy Research Foundation. Dr. Eschbach has a non-compensated relationship as a Medical Science Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Vito P. Arena, MD	Dr. Arena has nothing to disclose.
Breana Taylor, MD	Dr. Taylor has nothing to disclose.
James Grogan, MD	Dr. Grogan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Ashalatha Radhakrishnan, Sr., MD	Dr. Radhakrishnan has nothing to disclose.
Stephanie Gandelman, MD	Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Dr. Gandelman has received research support from Alexion Pharmaceuticals.
Sarah Mauney, DO	Dr. Mauney has nothing to disclose.
Harinoor Mann, MBBS	Dr. Mann has nothing to disclose.
Sanem P. Uysal, MD	Dr. Uysal has nothing to disclose.
Mellad Khoshnood, MD	Dr. Khoshnood has nothing to disclose.
Angela Catalina Vallejo Cajigas, MD	Dr. Vallejo Cajigas has nothing to disclose.
Saba Jafarpour, MD	Dr. Jafarpour has nothing to disclose.
Christian A. Sam, MD	Dr. Sam has nothing to disclose.
Jasmine Parihar, DM	Dr. Parihar has nothing to disclose.
Emily Casaletto	Miss Casaletto has nothing to disclose.
Isaac Smith, DO, MS	Dr. Smith has nothing to disclose.
Molly Perkins, MD	Dr. Perkins has nothing to disclose.
Mainak Bardhan, MD	Dr. Bardhan has nothing to disclose.
Ahmed Abdelhak, MD	The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society.
Raissa Aoun, MD	Dr. Aoun has nothing to disclose.
Sarah Shapiro	Miss Shapiro has nothing to disclose.
Mor Gueye	No disclosure on file
Joan Maley	No disclosure on file
Isabella Canut	Ms. Canut has nothing to disclose.
Soleil Samaan	No disclosure on file
Allaire Doussan	No disclosure on file
Tim Woelfle	The institution of Dr. Woelfle has received research support from Foundation Clinical Neuroimmunology and Neuroscience Basel. The institution of Dr. Woelfle has received research support from Swiss Innovation Agency (Innosuisse) – Project ID: 33535.1 IP-ICT.
Susana Dominguez Penuela, MD	Dr. Dominguez Penuela has nothing to disclose.
Hao Yiu	No disclosure on file
Milagros Galecio-Castillo, MD	Dr. Galecio-Castillo has nothing to disclose.
Chun-Yen Cheng	Chun-Yen Cheng has received personal compensation for serving as an employee of Bristol Myers Squibb. Chun-Yen Cheng has stock in Bristol Myers Squibb.
Alexandra Beaudry-richard	Alexandra Beaudry-richard has received research support from the Multiple Sclerosis Society of Canada. Alexandra Beaudry-richard has received research support from the Canadian Institutes of Health Research .
Herriot Tabuteau	Herriot Tabuteau has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Axsome Therapeutics.
Alex Aimetti	No disclosure on file
Carolina Parra Cantu, MD	Dr. Cantu has nothing to disclose.
Pedro Mena	Pedro Mena has nothing to disclose.
Lindsay Tetreault, MD, PhD	Dr. Tetreault has nothing to disclose.
Rosario Isasi	No disclosure on file
Michele Potashman, PhD	Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Daniel C. Kelly	Mr. Kelly has nothing to disclose.
Óscar G. Reyes Pupo, PhD	Dr. Reyes Pupo has nothing to disclose.
Maria Fernanda Ramos Sanchez	No disclosure on file
Jose Enciso	No disclosure on file
Carla Manrique Enciso	No disclosure on file
Shailesh Gaikwad	Shailesh Gaikwad has nothing to disclose.
Sarah Perman	No disclosure on file
Breton Asken	Breton Asken has nothing to disclose.
Jody Goldstein	No disclosure on file
Ario Mirian, MD	Dr. Mirian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Mirian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson.
Varun Kannan, MD	Dr. Kannan has nothing to disclose.
Adriana C. Rodriguez Leon, MD	Dr. Rodriguez Leon has nothing to disclose.
Janetta L. Arellano, MD	Dr. Arellano has nothing to disclose.
Yike Jiang	Yike Jiang has nothing to disclose.
Tim Erickson	No disclosure on file
Kristy Murray	No disclosure on file
Nihal Satyadev, MD, MPH	Dr. Satyadev has nothing to disclose.
Karin Zebenholzer, MD	Dr. Zebenholzer has nothing to disclose.
Leigh N. Sepeta, PhD	Dr. Sepeta has received personal compensation in the range of $500,000-$999,999 for serving as a Grant PI with Nih. Dr. Sepeta has a non-compensated relationship as a Special volunteer with Nih that is relevant to AAN interests or activities.
Paul Goldberg	Paul Goldberg has received personal compensation for serving as an employee of Prilenia. Paul Goldberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis Pharmaceuticals. Paul Goldberg has stock in Prilenia.
Estevao P. Ribeiro, MD	Dr. Ribeiro has nothing to disclose.
Lucy Gee, PhD	Dr. Gee has nothing to disclose.
Jacqueline Hirschey, MD	Dr. Hirschey has nothing to disclose.
Dylan T. Ryan, MD	Dr. Ryan has nothing to disclose.
Anvesh Balabhadra, MBBS	Dr. Balabhadra has nothing to disclose.
Christine Gummerson, MD	Dr. Gummerson has received personal compensation in the range of $0-$499 for serving as a NeuroBytes faculty contributor with ��ɫ��.
Nicholas J. Bellacicco, DO	Dr. Bellacicco has nothing to disclose.
Claudia Cruzalegui Bazán	Miss Cruzalegui Bazán has nothing to disclose.
Wilson E. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Manik Tetarbe, MD	Dr. Tetarbe has nothing to disclose.
Lydia Kauffman, MD	Dr. Kauffman has nothing to disclose.
Nik Krajnc	Nik Krajnc has nothing to disclose.
Megumi Sugita, DO	Dr. Sugita has nothing to disclose.
Hamza M. Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Evan Fields, MD	Dr. Fields has nothing to disclose.
Marie Varnet, MD	Dr. Varnet has nothing to disclose.
Shuodan Zhang, MD	Dr. Zhang has nothing to disclose.
Benjamin Hoehn	Benjamin Hoehn has received personal compensation for serving as an employee of Annexon.
Linda Mosher	No disclosure on file
Andi Liang, MD	Miss Liang has nothing to disclose.
Philion Gatchoff, MD	Dr. Gatchoff has nothing to disclose.
Philip T. Kuball, MD	Dr. Kuball has nothing to disclose.
Sarah Bou Reslan, MD	Dr. Bou Reslan has nothing to disclose.
Shayan A. Zadegan, MD	Dr. Zadegan has nothing to disclose.
Amr Salem, MBBCH	Dr. Salem has nothing to disclose.
Sailaja Sanikommu, MBBS	Dr. Sanikommu has nothing to disclose.
Sushil Yadav	No disclosure on file
Anudeeta Gautam	Miss Gautam has nothing to disclose.
Ahmed Esmael	No disclosure on file
Natalie Boyd	Natalie Boyd has nothing to disclose.
Trieste Francis	Miss Francis has nothing to disclose.
Karla Robles Lopez	Karla Robles Lopez has nothing to disclose.
Gregory S. Parks, PhD	Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
Morgan Morris	Morgan Morris has nothing to disclose.
Brittany Duncan	No disclosure on file
Eva Kitlen	No disclosure on file
Annie E. McDermott	Ms. McDermott has nothing to disclose.
Angad Chhabra	Angad Chhabra has nothing to disclose.
Kaitlyn Hay	No disclosure on file
Michael Parsons	No disclosure on file
Ilene Hollin	The institution of Ilene Hollin has received research support from MT Pharma. The institution of Ilene Hollin has received research support from PCORI. The institution of Ilene Hollin has received research support from PCORI. The institution of Ilene Hollin has received research support from Shriners Hospital for Children. The institution of Ilene Hollin has received research support from NIH/NIDDK. The institution of Ilene Hollin has received research support from NIH/NHLBI. Ilene Hollin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with New Horizons, a division of Global Health Labs.
Jaeleene Wijangco	Jaeleene Wijangco has nothing to disclose.
Madison M. Patrick	Ms. Patrick has nothing to disclose.
Pamela Wolters	No disclosure on file
Joshua Nahm	No disclosure on file
Shane Poole	Shane Poole has nothing to disclose.
Emma Krening, Other	Ms. Krening has nothing to disclose.
Ndonji Chiwaya, MD	Ndonji Chiwaya has nothing to disclose.
Dongliang Wang	Dongliang Wang has nothing to disclose.
Russell D'Aiello	No disclosure on file
Kelsey Owen	No disclosure on file
Braedon Kirkpatrick	Braedon Kirkpatrick has nothing to disclose.
Damien Eggenspieler	No disclosure on file
Giuseppe Fuda	No disclosure on file
Klaus Berek	Klaus Berek has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Klaus Berek has received personal compensation in the range of $500-$4,999 for serving as a travel compensation with Roche, Teva, Merck, Biogen, Sanofi, Novartis.
Yuka Martens	No disclosure on file
Birendra Sah	Birendra Sah has received publishing royalties from a publication relating to health care.
Sobin Pant, MBBS	Mr. Pant has nothing to disclose.
William Harmsen	William Harmsen has nothing to disclose.
Stefan Macher	Stefan Macher has nothing to disclose.
Ibolya Boer, MD	Ibolya Boer has received personal compensation for serving as an employee of Novartis AG.
Dragos Manta	Dragos Manta has nothing to disclose.
Michael Hayden	Michael Hayden has received personal compensation for serving as an employee of Prilenia Therapeutics. Michael Hayden has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CAMP4. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for AbCellera Biologics Inc.. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Ionis Pharmaceuticals . Michael Hayden has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 89 Bio. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Oxford Biomedica . Michael Hayden has stock in Ionis Pharmaceuticals. Michael Hayden has stock in AbCellera Biologics Inc.. Michael Hayden has stock in 89 Bio. The institution of Michael Hayden has received research support from Canadian Institutes of Health Research. The institution of Michael Hayden has received research support from National Research Council Canada. The institution of Michael Hayden has received research support from Huntington Society of Canada. The institution of Michael Hayden has received research support from Bev Hartig Huntington Disease Foundation. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care.
Joseph Dieleman, PhD	Prof. Dieleman has nothing to disclose.
Deepa Dongarwar	Deepa Dongarwar has nothing to disclose.
Riya A. Soneji	Miss Soneji has nothing to disclose.
Andrew Thorpe	No disclosure on file
Jasmine L. May, MD, PhD	An immediate family member of Dr. May has received personal compensation for serving as an employee of Doximity. An immediate family member of Dr. May has stock in Doximity.
Xiaoyi Gao, MD	Miss Gao has nothing to disclose.
Carlo Wilke	No disclosure on file
Sarah Levy, PhD	Dr. Levy has nothing to disclose.
Fatima Traore, MD	Dr. Traore has nothing to disclose.
William W. Lytton, MD	Dr. Lytton has nothing to disclose.
Martin C. Salinsky, MD	Dr. Salinsky has nothing to disclose.
Hector Lalama, MD	Dr. Lalama has nothing to disclose.
Hans Heinrich Jung, MD	Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylan. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Aventis. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Aventis. The institution of Dr. Jung has received research support from Swiss National Science Foundation.
Jacqueline Kraus, MD, PhD	Dr. Kraus has a non-compensated relationship as a Member with AAN that is relevant to AAN interests or activities.
William Benko, MD	Dr. Benko has received personal compensation in the range of $500-$4,999 for serving as a Expert- Surveys with Connected Research .
abby kunz, MD	Dr. Kunz has nothing to disclose.
Kai McGreevy, MD	Dr. McGreevy has nothing to disclose.
Stephanie Keller, MD	Dr. Keller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therpeutics. Dr. Keller has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for United Leukodystrophy Foundation. The institution of Dr. Keller has received research support from CHOP/NIH. The institution of Dr. Keller has received research support from IONIS. The institution of Dr. Keller has received research support from Biomarin. The institution of Dr. Keller has received research support from Boehring-Ingelheim.
Denizart Santos-Neto, MD	Dr. Santos-Neto has nothing to disclose.
Jens Claassen	No disclosure on file
David A. Hammer, MD	Dr. Hammer has nothing to disclose.
Jamie Elliott, MD, PhD	Dr. Elliott has nothing to disclose.
Mohammad Dastjerdi, MD	Dr. Dastjerdi has nothing to disclose.
Andreas Traschutz, MD	No disclosure on file
John Paul Aboubechara, MD, PhD	Dr. Aboubechara has nothing to disclose.
Ann Zheng, MD	Dr. Zheng has nothing to disclose.
Kimberly Kwei, MD, PhD	The institution of Dr. Kwei has received research support from New York Community Trust.
Antoinette O'Connor, MD	Dr. O'Connor has nothing to disclose.
Meenakshi Roy, MD	Dr. Roy has nothing to disclose.
Christiane Schmied	No disclosure on file
Hannah Harrison, MD, MBA	Dr. Harrison has nothing to disclose.
Reshma Punjani	Reshma Punjani has nothing to disclose.
Robert C. Goodrich III, MD	Dr. Goodrich has nothing to disclose.
Olivera Tamas	No disclosure on file
Abraham John, MD, MHA	Dr. John has nothing to disclose.
Jorge Jimenez	Jorge Jimenez has nothing to disclose.
Gaurav Nepal	Mr. Nepal has nothing to disclose.
Nhayoung Hwang, MD	Dr. Hwang has nothing to disclose.
May Zin Myint, MBBS	Dr. Myint has nothing to disclose.
Isabella Barcelos	No disclosure on file
Naga Pradyumna Kothapalli, MD	Dr. Kothapalli has nothing to disclose.
Martha E. Orozco Cortes, MD	Dr. Orozco Cortes has nothing to disclose.
Pardis Pooshpas, MD	Dr. Pooshpas has nothing to disclose.
Aparna Kalyani Pariyadath, MBBS	Dr. Pariyadath has nothing to disclose.
Lauren K. Offerle, MD	Dr. Offerle has nothing to disclose.
Tae Kim, MD	Dr. Kim has nothing to disclose.
Suhaira Ahmad	No disclosure on file
Getasha Doobay, MD	Dr. Doobay has nothing to disclose.
Marwa Baalbaki, MD	Dr. Baalbaki has nothing to disclose.
Toni Cao, MD	Dr. Cao has nothing to disclose.
Stephanie Vu, MD	Dr. Vu has nothing to disclose.
Lauren T. Gray, PhD	Dr. Gray has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alabama Dysphagia Conference. The institution of Dr. Gray has received research support from ALS Association. The institution of Dr. Gray has received research support from Department of Defense. The institution of Dr. Gray has received research support from ALS Association.
Adam L. Cohen, MD	The institution of Dr. Cohen has received research support from Chimerix. An immediate family member of Dr. Cohen has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NIH. Dr. Cohen has received personal compensation in the range of $100,000-$499,999 for serving as a EMployee with Inova.
Ariyana Bozzorg, MD	Dr. Bozzorg has nothing to disclose.
Gabrielle T. Ghabash	Ms. Ghabash has nothing to disclose.
Jillian Prier, MD	Dr. Prier has nothing to disclose.
Suraj Malhan, DO	Dr. Malhan has nothing to disclose.
Stefano Pisano, MD	Dr. Pisano has nothing to disclose.
Lucia Liao, MD	Dr. Liao has nothing to disclose.
Patricia Jokl Graese, MD	Dr. Graese has nothing to disclose.
Charles Jake Sadle, DO	Dr. Sadle has nothing to disclose.
Yugant Khand, MBBS, DiMM	Dr. Khand has nothing to disclose.
Nezar Khatib, MD	Dr. Khatib has nothing to disclose.
JoBeth D. Bingham, DO	Dr. Bingham has nothing to disclose.
Aygun Asgarli, MD	Dr. Asgarli has nothing to disclose.
Ashley N. Hackett, MD	Dr. Hackett has nothing to disclose.
Surjeet Kundi, MD	Dr. Kundi has nothing to disclose.
Jason Gandhi, MD	Dr. Gandhi has nothing to disclose.
Nimit N. Desai, MD	Dr. Desai has nothing to disclose.
Michelle Tsai, MD	Dr. Tsai has nothing to disclose.
Alexa L. Carreras, MD	Dr. Carreras has nothing to disclose.
Sandro Luiz de Andra Matas	No disclosure on file
Henry J. Bockholt	The institution of Henry Bockholt has received research support from NIH. The institution of an immediate family member of Henry Bockholt has received research support from NIH.
Mai Bang Poulsen	No disclosure on file
Saori L. Haigo, MD, PhD	Dr. Haigo has nothing to disclose.
Sidharth Suresh, MD, MBBS	Dr. Suresh has nothing to disclose.
S M Krishna M. Mavuru, MD, MBBS	Dr. Mavuru has nothing to disclose.
Samantha Sweeney, Other	Dr. Sweeney has received personal compensation for serving as an employee of Pfizer. Dr. Sweeney has stock in Pfizer.
Catherine Joseph, NP	Ms. Joseph has nothing to disclose.
Amy Young, MD	Dr. Young has nothing to disclose.
Ramshekhar N. Menon, MD, MBBS, DM; PDF	Dr. MENON has nothing to disclose.
Ashish D. Patel, MD	An immediate family member of Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Patel has stock in Ocular Therapeutix. Dr. Patel has stock in Autolus Therapeutics . Dr. Patel has stock in Larimar Therapeutics. Dr. Patel has stock in Viking Therapeutics. An immediate family member of Dr. Patel has stock in Voyager Therapeutics. An immediate family member of Dr. Patel has stock in BridgeBio Pharma, Inc.. An immediate family member of Dr. Patel has stock in Stoke Therapeutics. The institution of an immediate family member of Dr. Patel has received research support from The Patient-Centered Outcomes Research Institute.
Mittal S. Prajapati, MD	Dr. Prajapati has nothing to disclose.
Saif S. Bawaneh, MD	Dr. Bawaneh has nothing to disclose.
Priscilla Yan, MD	Dr. Yan has nothing to disclose.
Ruben Jauregui, MD	Dr. Jauregui has nothing to disclose.
Kajol H. Doshi, MD	Dr. Doshi has nothing to disclose.
Christian Rojas Cerón	Christian Rojas Cerón has nothing to disclose.
Jairo Lizarazo Niño	Jairo Lizarazo Niño has nothing to disclose.
JUAN ROJAS	JUAN ROJAS has nothing to disclose.
FERNANDO ROSSO	No disclosure on file
Sanya Ahmed	Ms. Ahmed has nothing to disclose.
Jason Liu, MD	Mr. Liu has nothing to disclose.
Megan N. Thomas, MD	Dr. Thomas has nothing to disclose.
Esther Macken, MD	Dr. Macken has nothing to disclose.
Dylan A. Selbst	Mr. Selbst has nothing to disclose.
Takuya Kudo	Mr. Kudo has nothing to disclose.
Victoria C. Eon, CRC	Ms. Eon has received personal compensation for serving as an employee of QurAlis Corporation.
Amanda Jan	Mrs. Jan has nothing to disclose.
Tejaswini Jagtap	Ms. Jagtap has nothing to disclose.
Hariharan Venkataraman, MBBS	Mr. Venkataraman has nothing to disclose.
Helena Yan, MD	Ms. Yan has nothing to disclose.
Hamza Khan-Tareen, MD	Dr. Khan-Tareen has nothing to disclose.
Kirsten Consing, DO	Dr. Consing has nothing to disclose.
Sudheesh Ramachandran, MBBS	Dr. Ramachandran has nothing to disclose.
Reena Bastin, MD	Dr. Bastin has nothing to disclose.
Nishel Y. Kothari, MBBS	Dr. Kothari has nothing to disclose.
Gunjanpreet Kaur, MD	Dr. Kaur has nothing to disclose.
Maria Belen Solis Mayorga, MD	Dr. Solis Mayorga has nothing to disclose.
Zainab Al Obaidi, MD	Dr. Al Obaidi has nothing to disclose.
Toluwanimi A. Shaanu, MBBS	Dr. Shaanu has nothing to disclose.
Feilin Liu, MD	Dr. Liu has nothing to disclose.
Sreya Devarakonda	Miss Devarakonda has nothing to disclose.
Tabassum Chowdhury, MD	Ms. Chowdhury has nothing to disclose.
Monica L. Janz, MD	Miss Janz has nothing to disclose.
Shiv K. Jha, MBBS	Dr. Jha has nothing to disclose.
Danielle Silverman	Ms. Silverman has nothing to disclose.
Frank J. Franzino III, Other	Mr. Franzino has nothing to disclose.
Luis Fernandez	No disclosure on file
Priya Mainali	No disclosure on file
Tommaso Nicoletti, MD	Dr. Nicoletti has nothing to disclose.
Ana Barragan	No disclosure on file
Nils Briel, Jr., MD	Dr. Briel has nothing to disclose.
Shuhei Shiino	Mr. Shiino has nothing to disclose.
Amber R. Hughes	Miss Hughes has nothing to disclose.
Jamie L. Fraser, MD, PhD	The institution of Dr. Fraser has received research support from NIH.
Alejandro Ena Bernad	No disclosure on file
Randal Hand	Dr. Hand has received personal compensation for serving as an employee of Prilenia Therapeutics.
Michal Geva	Michal Geva has received personal compensation for serving as an employee of Prilenia Therapeutics. Michal Geva has received intellectual property interests from a discovery or technology relating to health care.
Rhea Shishodia	No disclosure on file
Kristina Johnson	Ms. Johnson has received personal compensation for serving as an employee of QurAlis. Ms. Johnson has stock in QurAlis.
Surabhi A. Garg, MD	Dr. Garg has nothing to disclose.
Kristiana Salmon, Other	Miss Salmon has received personal compensation for serving as an employee of QurAlis Corporation. Miss Salmon has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ProJenX. Miss Salmon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with ALS Canada.
Erik Deboer	Erik Deboer has received personal compensation for serving as an employee of BMS.
James Kelbert	Mr. Kelbert has nothing to disclose.
Gabriela Lopes, NP	Mrs. Lopes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceutical.
Madilyn L. Feik	Miss Feik has nothing to disclose.
Michelanthony L. Rosado-Velazquez, Medical Student	Mr. Rosado-Velazquez has nothing to disclose.
Emaan Fawad, Other	Miss Fawad has nothing to disclose.
Fajar Fawad, Other	Miss Fawad has nothing to disclose.
Rick Meeker	No disclosure on file
Muhammad Ahmed Ayaz, MBBS	Dr. Ayaz has nothing to disclose.
Fang Yu, MD	Dr. Yu has nothing to disclose.
Shatha Wahbi	Ms. Wahbi has nothing to disclose.
Chloe LaRochelle, MD	Miss LaRochelle has nothing to disclose.
Melanie Li, MD	Dr. Li has nothing to disclose.
Helena Xeros, MD	Dr. Xeros has nothing to disclose.
Kelsey Trace, OTD	Dr. Trace has received personal compensation for serving as an employee of National Ataxia Foundation.
Frank Ramirez	Mr. Ramirez has nothing to disclose.
Rohan N. Patel	Mr. Patel has nothing to disclose.
Jordanne Kirschke	Ms. Kirschke has nothing to disclose.
Bijoya Basu	Miss Basu has nothing to disclose.
Japleen Kaur, MBBS	Dr. Kaur has nothing to disclose.
Victoria Damore	Miss Damore has nothing to disclose.
Linjun Cai, PhD	Linjun Cai has nothing to disclose.
Veronica Cipriani, MD	No disclosure on file
Jeremy D. Dalos	Mr. Dalos has nothing to disclose.
Jennifer Jolivert	No disclosure on file
Grace Wu	No disclosure on file
Chiara Giuseppina Bonomi	No disclosure on file
Hiromi Terai	Miss Terai has nothing to disclose.
Eleanor Anderson	No disclosure on file
Chintal T. Patel, MD	Ms. Patel has nothing to disclose.
Rutu Patel, PA	Ms. Patel has nothing to disclose.
Sangharsha Thapa, MD	Dr. Thapa has nothing to disclose.
Felix Heindl	Felix Heindl has nothing to disclose.
Annette Hartmann	Annette Hartmann has nothing to disclose.
Giulia Del Gobbo	No disclosure on file
Muskan Rawoot, MD	Ms. Rawoot has nothing to disclose.
Morris Jrada	No disclosure on file
Alexanne Cuillerier	No disclosure on file
Radhika Amin, MPH	Ms. Amin has nothing to disclose.
Karishma Kashyap	No disclosure on file
Melissa Ly, MD	Miss Ly has nothing to disclose.
Abigail H. Sorenson	Ms. Sorenson has nothing to disclose.
Justin D. Bessette	Mr. Bessette has nothing to disclose.
Mie R. Mahler, MD	The institution of Miss Mahler has received research support from Copenhagen University Hospital - Rigshospitalet's research fund. Miss Mahler has a non-compensated relationship as a participant in a scientific meeting with Merck that is relevant to AAN interests or activities.
Thanya Lagos	Thanya Lagos has nothing to disclose.
Monica Tran	No disclosure on file
Ambar M. MORALES-RODRIGUEZ, MD	Dr. MORALES-RODRIGUEZ has nothing to disclose.
Allan Fisher	No disclosure on file
Laura Chisholm	Laura Chisholm has nothing to disclose.
Hannah Coco	No disclosure on file
My H. Nguyen	Miss Nguyen has nothing to disclose.
John Flatt	No disclosure on file
Sophie Ohrn	Ms. Ohrn has nothing to disclose.
Beata Daniluk	No disclosure on file
Tyler Arnwine	No disclosure on file
Anima Shrestha, MD	Miss Shrestha has nothing to disclose.
Dan Rujescu	Dan Rujescu has nothing to disclose.
Ryan Ramphul	Ryan Ramphul has nothing to disclose.
Mario G. Chavez Hermosilla	Mr. Chavez Hermosilla has nothing to disclose.
Yixin Chen	No disclosure on file
Sandy Hinckley	No disclosure on file
Dan Elbaum	No disclosure on file
John Polzer	No disclosure on file
Harmandeep Singh Brar	No disclosure on file
Madhavi Tripathi	Madhavi Tripathi has nothing to disclose.
Celeste Suart	No disclosure on file
Maria Pedersen	No disclosure on file
Rakhee Ganti	No disclosure on file
Francesca Palumbo	Dr. Palumbo has nothing to disclose.
Julia Noreck	Julia Noreck has nothing to disclose.
Tara Szymanski	No disclosure on file
Benjamin Vogel	Benjamin Vogel has nothing to disclose.
Clarida Martinez	No disclosure on file
Natalie Beck	Natalie Beck has nothing to disclose.
Samantha Rubino	No disclosure on file
Sophie Kushman	No disclosure on file
Alique G. Topalian, PhD, MPH	Dr. Topalian has nothing to disclose.
Lina Nguyen	Lina Nguyen has nothing to disclose.
Michelle Hearn	No disclosure on file
Luigi Pontieri	No disclosure on file
Patricio Castro Suarez	Mr. Castro Suarez has nothing to disclose.
Sarah Petersen	No disclosure on file
Xueying Liu	No disclosure on file
Jordan Abbott	No disclosure on file
Sterling Kosmach	No disclosure on file
Abel M. Thomas	Mr. Thomas has nothing to disclose.
Amina Namrouti, MD	Miss Namrouti has nothing to disclose.
Sadeepa Bulathsinhala	No disclosure on file
Kirtana Ananth	An immediate family member of Kirtana Ananth has received personal compensation in the range of $10,000-$49,999 for serving as a Whole Time Member with Securities and Exchange Board of India (SEBI).
Gouthami Sajjanagandla	No disclosure on file
Maxwell Dacquel	No disclosure on file
Erica Ma	No disclosure on file
Ben Emery	No disclosure on file
Krystyna C. Phillips, MD	Ms. Cios has received research support from National Institutes of Health.
Nathan Rabinovitch	No disclosure on file
Surbhi Mathur	No disclosure on file
Courtney N. Nguyen	Ms. Nguyen has nothing to disclose.
Sonia Nocera	No disclosure on file
Frederik Elberling	No disclosure on file
Yasuko Mori, Sr., MD	Dr. Mori has nothing to disclose.
Noel Fanning	No disclosure on file
Margaux Poleur	No disclosure on file
Mulenga Chilando	Mulenga Chilando has nothing to disclose.
Bryan Boggs	No disclosure on file
Timothy Ko	Timothy Ko has nothing to disclose.
Carmenrita Infortuna	Carmenrita Infortuna has nothing to disclose.
Benjamin Vlad	No disclosure on file
Arashleen K. Pannu	Ms. Pannu has nothing to disclose.
Daniel Kotas	Mr. Kotas has nothing to disclose.
Jasmine Berry	Jasmine Berry has nothing to disclose.
Greg Duncan	No disclosure on file
Anna Maria Reuss	No disclosure on file
Antonio Bruno	No disclosure on file
Lindsey Kuchenbecker	Lindsey Kuchenbecker has nothing to disclose.
Andrea Bink	No disclosure on file
Katherine Beshears	Ms. Beshears has nothing to disclose.
Evangelos Oikonomou	No disclosure on file
Hannah Phelps	No disclosure on file
ANITA GRACEFFA	No disclosure on file
Erica Kreisberg	No disclosure on file
You Hernandez	No disclosure on file
Juan Perez Hernandez	No disclosure on file
Tina Singh	No disclosure on file
Sangam Shah	Dr. Shah has nothing to disclose.
Krishna Dahal	No disclosure on file
Shannon Giliberto	Mrs. Giliberto has nothing to disclose.
Jonathan Terry	No disclosure on file
Lauren Canha	No disclosure on file
Maria Buccafusca	No disclosure on file
Enrica Maiorana	No disclosure on file
Robert Edwards	No disclosure on file
Satoko Miyatake	No disclosure on file
Shir Lynn Lim	No disclosure on file
Bigyan Paudel	No disclosure on file
Lena Deb	Lena Deb has nothing to disclose.
Blaine Cloud, PhD	Dr. Cloud has nothing to disclose.
Wenjia Wei	Wenjia Wei has received personal compensation for serving as an employee of Novartis.
Yue Liu	Ms. Liu has nothing to disclose.
Divya Thomas	No disclosure on file
Lori Silveira	No disclosure on file
Ajitesh Nanda	Ajitesh Nanda has nothing to disclose.
Karl Frontzek	No disclosure on file
Sarah M. Kovalev, RA	Miss Kovalev has nothing to disclose.
George P. Slavinski, Respiratory Therapist	Mr. Slavinski has nothing to disclose.
Alexander Ratzan	No disclosure on file
Venkatsampath Raja Gogineni	Venkatsampath Raja Gogineni has nothing to disclose.
P Elliott Miller	P Elliott Miller has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JCF-I.
Noah Kim	No disclosure on file
Derek L. Chien	Mr. Chien has nothing to disclose.
Yang Yi	No disclosure on file
Martina Poli	No disclosure on file
Leland Barnard	Leland Barnard has nothing to disclose.
Sijan Karki	No disclosure on file
Akhil Khosla	Akhil Khosla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inari.
Teresa Capella	Teresa Capella has nothing to disclose.
Nirmala Ghimirey, DO	Dr. Ghimirey has nothing to disclose.
Kathy Phipps	No disclosure on file
Muhammad Ibrahim	Muhammad Ibrahim has nothing to disclose.
Claudia Raines	No disclosure on file
Paul Slaughter	No disclosure on file
Birgit Andersen	No disclosure on file
Baggio Evangelista	No disclosure on file
Christina Durrough	No disclosure on file
Ian Tang, PhD	Dr. Tang has received research support from NIH.
Wilfried Rossoll	No disclosure on file
Todd Cohen	No disclosure on file
Christine Nguyen	Miss Nguyen has nothing to disclose.
Antje Mefferd	No disclosure on file
Evan Stein	No disclosure on file
Alissa Algarin	No disclosure on file
Daniel Kim	No disclosure on file
Nora Jabassini	No disclosure on file
Katie Liu	No disclosure on file
Eitan Raveh	No disclosure on file
Lauren Carito	No disclosure on file
Frances M. Aponte-Caraballo, MS	Miss Aponte-Caraballo has received personal compensation for serving as an employee of Fundación ALS de Puerto Rico. Miss Aponte-Caraballo has received research support from AIM-AHEAD Data Science Training Core Training Practicum (PRIME) Program.
Kristina Vaughn	No disclosure on file
William Siwik	No disclosure on file
Andres Chavez-Barragan	No disclosure on file
Marta Schumacher	No disclosure on file
AJ Mitchell, PhD	Dr. Mitchell has nothing to disclose.
Peter Collins	Peter Collins has received personal compensation for serving as an employee of Annexon Biosciences. An immediate family member of Peter Collins has received personal compensation for serving as an employee of Wikipedia.
Zihan Sun	No disclosure on file
Maria Rudrud	No disclosure on file
Pedro Saldanha de Castro	No disclosure on file
Natalie Bovin	No disclosure on file
Angela Apeagyei	Angela Apeagyei has nothing to disclose.
Alexis Tricot	No disclosure on file
Alex Pinto	No disclosure on file
Lauren Moore, PhD	Dr. Moore has nothing to disclose.
Esha Mahalingam	No disclosure on file
Allen Omo-Ogboi	No disclosure on file
William Adams	No disclosure on file
Forat Lutfi	No disclosure on file
Joshua Katz	No disclosure on file
Lei Xu	No disclosure on file
Mehrdad Haghpassand	No disclosure on file
Jayesh Mehta	No disclosure on file
Michael Newton	No disclosure on file
Nathanial Eddy	Nathanial Eddy has received personal compensation for serving as an employee of Bristol Myers Squibb. Nathanial Eddy has stock in Bristol Myers Squibb.
Rivka Kreitman	No disclosure on file
Rashiqah Syed	No disclosure on file
Emily Allen	No disclosure on file
Ryan Ransom	No disclosure on file
Zenggang Pan	No disclosure on file
Abeeha Mirza	No disclosure on file
Eriko Koshimizu	No disclosure on file
Binoy Yohannan	No disclosure on file
Erin Owen	No disclosure on file
Nikki Sisodia	Nikki Sisodia has nothing to disclose.
Rania Issa, MD	Dr. Issa has nothing to disclose.
Kathryn Emily	No disclosure on file
Benjamin A. Hull	Mr. Hull has nothing to disclose.
Manisha Satheesh	Ms. Satheesh has nothing to disclose.
Sofia Aranda	No disclosure on file
Devin Weber	No disclosure on file
Spencer Brown	No disclosure on file
Ali Pourmand	Ali Pourmand has nothing to disclose.
Julie C Fanburg-Smith	No disclosure on file
Aliyah Mohammed	No disclosure on file
Young Heng Chee	No disclosure on file
Joseph Thirumalareddy	No disclosure on file
Merritt Reece	No disclosure on file
Bernadette Siaton	No disclosure on file
Ahmed Taha Shahzad	Mr. Shahzad has nothing to disclose.
Rohan Khera	No disclosure on file
Ze Ou, DBBS	Mr. Ou has nothing to disclose.
Chimuka Muleya	No disclosure on file
Timothy Zhang	Timothy Zhang has nothing to disclose.
Paul Strijbos	No disclosure on file
Omer Berkman	No disclosure on file
Fabrizio Chiodo	No disclosure on file
Celine Cluzeau	No disclosure on file
Cristina De Castro	No disclosure on file
Claire Zurlo	No disclosure on file
Sagar Mehta	No disclosure on file
Yuichi Hayashi	No disclosure on file
Rosa Rosario-Rosado	No disclosure on file
Nicholson Modesti	No disclosure on file
John Stone	No disclosure on file
Jason Kimmerly	No disclosure on file
Jason Osik	Jason Osik has received personal compensation for serving as an employee of Bristol Myers Squibb. Jason Osik has stock in Bristol Myers Squibb. Jason Osik has received intellectual property interests from a discovery or technology relating to health care.
Anjana Sevagamoorthy	No disclosure on file
Hanaan Bing-Canar, PhD	Dr. Bing-Canar has nothing to disclose.
Michael De Riesthal	No disclosure on file
Jordan Goodman	No disclosure on file
Pranav Patel	No disclosure on file
Lee Kugelmann	Lee Kugelmann has nothing to disclose.
ISTONI DA LUZ SANTANA	No disclosure on file
Brandon Molligoda	Mr. Molligoda has nothing to disclose.
Denise Acevedo	No disclosure on file
Sebastian Werneburg	No disclosure on file
Dustin Begosh-Mayne	No disclosure on file
Ana Saldarriaga-Mayo	Ana Saldarriaga-Mayo has nothing to disclose.
Ismael Araujo-Aliaga	No disclosure on file
Kyra Henderson	Kyra Henderson has nothing to disclose.
Edmund Ben-Ami	No disclosure on file
Emilie Lommers	No disclosure on file
Jung Sin	No disclosure on file
Ian Cogswell	Ian Cogswell has nothing to disclose.
Richard S. Rodriguez	No disclosure on file
Vinh Nguyen	No disclosure on file
AJ Rathakrishnan	No disclosure on file
Ian George	No disclosure on file
Vanessa Kirschke	Ms. Kirschke has nothing to disclose.
Igor Khvylia, MD	Mr. Khvylia has nothing to disclose.
Samantha D'souza	No disclosure on file
Vaishnavi Rao	No disclosure on file
Amy Pizzino	No disclosure on file
John Encandela	No disclosure on file
Theresa Shankanga	Miss Shankanga has nothing to disclose.
Diwell Mwansa	Diwell Mwansa has nothing to disclose.
Marc Wish	No disclosure on file
Blaire Cote	No disclosure on file
Kevin Sheng-Kai Ma	Dr. MA has nothing to disclose.
Inga Urbonaviciute	No disclosure on file
Jim Rowson	No disclosure on file
Xinhai Zhang	No disclosure on file
Kanishka Koshal	No disclosure on file
Natalie Stanley	No disclosure on file
Brian Mangal	No disclosure on file
Sameeksha Bhama	No disclosure on file
Siddharth Agrawal	No disclosure on file
DUANE DEDE	No disclosure on file
Jason Soden	No disclosure on file
Sara Simeoni	No disclosure on file
David Isaacs	No disclosure on file
Plamen Bekyarov	No disclosure on file
Rajan Chamlagain	No disclosure on file
DIEGO FRANCISCO LIZARAZO ORTEGA	No disclosure on file
Emmy Abraham	No disclosure on file
Elisabeth Boudriot	No disclosure on file
P Sarat Chandra	P Sarat Chandra has nothing to disclose.
J.M.Monica Van De Ridder	No disclosure on file
Bertrand Degos	No disclosure on file
Laurie Medard	No disclosure on file
Mona Michaud	No disclosure on file
Golsum Tsakalos	Golsum Tsakalos has nothing to disclose.
Ariana Gaspert	No disclosure on file
Johanna Schmidt	No disclosure on file
Birgit Helmchen	No disclosure on file
Mirjana Djakovic	No disclosure on file
Leighton Chan	No disclosure on file
Willard Kasoff	No disclosure on file
Salma Almutairi	No disclosure on file
Rand M. Alanazi	Ms. Alanazi has nothing to disclose.
Norah Almuzil	No disclosure on file
Gillian Ciaccio	No disclosure on file
Martina Gaia Di Donna	No disclosure on file
Iman Fathali	No disclosure on file
Kimberly Harbough	No disclosure on file
Hui Li	No disclosure on file
Alessandro Martorana	No disclosure on file
Nicola Biagio Mercuri	No disclosure on file
Kinjal Patel	Kinjal Patel has nothing to disclose.
Rehana Persaud	No disclosure on file
Daniel Pollyea	No disclosure on file
Marielle Posmik	Marielle Posmik has nothing to disclose.
James Appio	James Appio has received personal compensation for serving as an employee of Bristol Myers Squibb. James Appio has stock in Bristol Myers Squibb.
John A. Flatt, MD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��